Processing 00000000.tx.1: Nitric oxide-induced cardioprotection in cultured rat ventricular myocytes Roby D. 

Phrase: "Nitric oxide-induced cardioprotection in cultured rat ventricular myocytes Roby D."
Processing 00000000.tx.2: Rakhit1, Richard J. 

Phrase: "Rakhit1,"

Phrase: "Richard J."
Processing 00000000.tx.3: Edwards1, James W. 

Phrase: "Edwards1,"

Phrase: "James W."
Processing 00000000.tx.4: Mockridge1, Anwar R. 

Phrase: "Mockridge1,"

Phrase: "Anwar R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.5: Baydoun1, Amanda W. 

Phrase: "Baydoun1,"

Phrase: "Amanda W."
Processing 00000000.tx.6: Wyatt2, G. 

Phrase: "Wyatt2,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.7: E. 

Phrase: "E."
Processing 00000000.tx.8: Mann2, and Michael S. 

Phrase: "Mann2,"

Phrase: "and"

Phrase: "Michael S."
Processing 00000000.tx.9: Marber1 1Department of Cardiology, St. 

Phrase: "Marber1 1Department of Cardiology,"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.10: Thomas' Hospital, and 2Department of Physiology, Centre for Cardiovascular Biology and Medicine, Kings College, London SE1 7EH, United Kingdom  ABSTRACT TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES The aim of this study was to investigate the role of nitric oxide (NO) in a cellular model of early preconditioning (PC) in cultured neonatal rat ventricular myocytes. 

Phrase: "Thomas' Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "and"

Phrase: "2Department of Physiology,"

Phrase: "Centre for Cardiovascular Biology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013227:Medicine, NOS [Pharmacologic Substance]
  1000   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "Kings College,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0557806:College [Manufactured Object]

Phrase: "London SE1 7EH,"

Phrase: "United Kingdom  ABSTRACT TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The aim of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1947946:Aim [Idea or Concept]
   760   C2948600:Aim [Pharmacologic Substance]
   760   C3540471:AIM [Gene or Genome]
   760   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the role of nitric oxide (NO)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in a cellular model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "of early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "preconditioning (PC) in cultured neonatal rat ventricular myocytes."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   748   C0018827:Ventricular [Body Part, Organ, or Organ Component]
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0596981:Myocytes [Cell]
   748   C0871117:Preconditioning [Mental Process]
   748   C1522565:Ventricular [Spatial Concept]
   748   C1552240:Neonatal [Professional or Occupational Group]
   748   C1552264:Neonatal [Professional or Occupational Group]
   748   C2939425:Neonatal [Temporal Concept]
   745   C2339371:Ventricular myocyte [Cell]
   714 E C1709632:Precondition [Conceptual Entity]
Processing 00000000.tx.11: Cardiomyocytes "preconditioned" with 90min of stimulated ischemia (SI) followed by 30min reoxygenation in normal culture conditions were protected against subsequent 6h of SI. 

Phrase: "Cardiomyocytes """
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "preconditioned"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0871117:precondition [Mental Process]
   966   C1709632:Precondition [Conceptual Entity]

Phrase: """"

Phrase: "with 90min"

Phrase: "of stimulated ischemia (SI)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022116:Ischaemia [Disease or Syndrome]
   789 E C0475224:Ischaemic [Functional Concept]

Phrase: "followed by 30min reoxygenation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0332283:Followed by [Temporal Concept]
           followed
   737 E C1719822:Follow [Intellectual Product]

Phrase: "in normal culture conditions"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   896   C0231162:Normal condition [Finding]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "protected against subsequent 6h of SI."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0022116:Ischaemia [Disease or Syndrome]
   748   C0332282:Subsequent [Temporal Concept]
   748   C1292428:6H [Temporal Concept]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
Processing 00000000.tx.12: PC was blocked by NG-monomethyl-L-arginine monoacetate but not by dexamethasone pretreatment. 

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "was"

Phrase: "blocked by NG-monomethyl-L-arginine monoacetate"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   853   C0069477:NG-Monomethyl-L-Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C0439297:ng/L [Quantitative Concept]
   748   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0028778:Blocked [Pathologic Function]
   748   C0332206:Blocked [Functional Concept]
   748   C2983591:BLOCKED [Research Activity]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]

Phrase: "but"

Phrase: "not by dexamethasone pretreatment."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   770   C1518422:Not [Functional Concept]
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]
   715 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   715 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   715 E C0740057:Decadron [Pharmacologic Substance,Steroid]
Processing 00000000.tx.13: Inducible nitric oxide synthase (NOS) protein expression was not detected during PC ischemia. 

Phrase: "Inducible nitric oxide synthase (NOS) protein expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1171362:protein expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
   734   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected during"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0442726:Detected [Finding]
   833   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "ischemia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022116:Ischaemia [Disease or Syndrome]
   928 E C0475224:Ischaemic [Functional Concept]
Processing 00000000.tx.14: Pretreatment (90min) with the NO donor S-nitroso-N-acetyl-L,L-penicillamine (SNAP) mimicked PC, resulting in significant protection. 

Phrase: "Pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1550147:Pretreatment [Substance]
  1000   C2709094:pre treatment [Temporal Concept]
  1000   C3539075:Pretreatment [Temporal Concept]
  1000   C3539076:Pretreatment [Activity]

Phrase: "(90min"

Phrase: ")"

Phrase: "with the NO donor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0600437:nitric oxide donor [Pharmacologic Substance]
   827   C0013018:Donor [Population Group]
   827   C0040288:Donor [Population Group]
   827   C1527169:Donor NOS [Finding]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "S-nitroso-N-acetyl-L,L-penicillamine (SNAP)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   740 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "mimicked"

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: ","

Phrase: "resulting in significant protection."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0332294:Resulting in [Functional Concept]
   770   C0237881:significant [Quantitative Concept]
   770   C0678226:resulting [Functional Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1545588:Protection [Finding]
   770   C1546944:Significant [Qualitative Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]
Processing 00000000.tx.15: SNAP-triggered protection was completely abolished by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) but was unaffected by chelerythrine or the presence of glibenclamide and 5-hydroxydecanoate. 

Phrase: "SNAP-triggered protection"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   842   C0439394:s l [Quantitative Concept]
   791   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   791   C1545588:Protection [Finding]
   791   C2603362:S' [Clinical Attribute]
   758   C0032930:Trigger [Clinical Attribute]
   758   C1444748:Trigger [Qualitative Concept]
   735 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "abolished by 1H-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1442450:1H [Temporal Concept]

Phrase: "[1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4"

Phrase: "]oxadiazolo"

Phrase: "[4,"

Phrase: "3-a]quinoxalin-1-one (ODQ)"

Phrase: "but"

Phrase: "was"

Phrase: "unaffected by chelerythrine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986417:Unaffected [Conceptual Entity]

Phrase: "or"

Phrase: "the presence of glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "5-hydroxydecanoate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0098450:5-hydroxydecanoate [Lipid,Pharmacologic Substance]
Processing 00000000.tx.16: With the use of RIA, SNAP treatment increased cGMP levels, which were blocked by ODQ. 

Phrase: "With the use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of RIA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034580:RIA [Laboratory Procedure]

Phrase: "SNAP treatment"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   850   C0439394:s l [Quantitative Concept]
   793   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   793   C0039798:treatment [Functional Concept]
   793   C0087111:Treatment [Therapeutic or Preventive Procedure]
   793   C1522326:Treatment [Functional Concept]
   793   C1533734:Treatment [Therapeutic or Preventive Procedure]
   793   C1705169:Treatment [Conceptual Entity]
   793   C2603362:S' [Clinical Attribute]
   793   C3538994:TREATMENT [Research Activity]
   737 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "cGMP levels,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0018338:cGMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "which"

Phrase: "were"

Phrase: "blocked by ODQ."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.17: Hence, NO is implicated as a trigger in this model of early PC via activation of a constitutive NOS isoform. 

Phrase: "Hence,"

Phrase: "NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "is"

Phrase: "implicated as a trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032930:Trigger [Clinical Attribute]
   770   C1444748:Trigger [Qualitative Concept]

Phrase: "in this model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "of early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "PC via activation of a constitutive NOS isoform."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   782   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   760   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   739   C0030015:oxide [Inorganic Chemical]
   739   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   739   C0871117:Preconditioning [Mental Process]
   739   C1879547:Activation [Activity]
   739   C2986642:oxide [Chemical Viewed Functionally]
   706 E C1709632:Precondition [Conceptual Entity]
Processing 00000000.tx.18: After exposure to SNAP, the mechanism of cardioprotection is cGMP dependent but independent of protein kinase C or ATP-sensitive K+ channels. 

Phrase: "After exposure to SNAP,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   791   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   735 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "the mechanism of cardioprotection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "cGMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018338:cGMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]

Phrase: "but independent of protein kinase C"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   820 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0332291:Independent of [Functional Concept]
   783   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   783   C1168438:Protein C [Laboratory Procedure]
   783   C1418943:PROTEIN C [Gene or Genome]
   783   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0085862:Independent [Idea or Concept]
   753   C0233535:but [Mental or Behavioral Dysfunction]
   753   C1299583:Independent [Finding]

Phrase: "or"

Phrase: "ATP-sensitive K+ channels."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0332324:Sensitive [Functional Concept]
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1550474:sensitive [Idea or Concept]
   812   C1708601:K' [Quantitative Concept]
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.19: This differs from the proposed mechanism of NO-induced cardioprotection in late PC. 

Phrase: "This"

Phrase: "differs from the proposed mechanism of NO-induced cardioprotection"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   739   C0030015:oxide [Inorganic Chemical]
   739   C0205263:Induced [Functional Concept]
   739   C0441712:Mechanism [Functional Concept]
   739   C1441414:PROPOSED [Idea or Concept]
   739   C1553874:Proposed [Qualitative Concept]
   739   C1578820:Proposed [Idea or Concept]
   739   C1706376:Mechanism [Manufactured Object]
   739   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "in late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205087:Late [Temporal Concept]

Phrase: "PC."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]
Processing 00000000.tx.20: guanosine 3'-cyclic monophosphate; 

Phrase: "guanosine 3'-cyclic monophosphate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0018338:Guanosine Cyclic Monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   902   C0018346:Guanosine Monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.21: nitric oxide synthase; 

Phrase: "nitric oxide synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ";"
Processing 00000000.tx.22: ischemic preconditioning; 

Phrase: "ischemic preconditioning"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0376466:Ischemic Pre-Conditioning [Therapeutic or Preventive Procedure]
   861   C0475224:Ischaemic [Functional Concept]
   861   C0871117:Preconditioning [Mental Process]
   827 E C1709632:Precondition [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.23: protein kinase C; 

Phrase: "protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.24: adenosine 5'-triphosphate-sensitive potassium channel  INTRODUCTION TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES NITRIC OXIDE (NO) is a ubiquitous modulator of biological processes, and a number of important roles have emerged implicating it in a wide spectrum of cardiovascular disease (38). 

Phrase: "adenosine 5'-triphosphate-sensitive potassium channel  INTRODUCTION TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   786   C0557061:Discussion [Therapeutic or Preventive Procedure]
   786   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "NITRIC OXIDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ")"

Phrase: "is"

Phrase: "a ubiquitous modulator of biological processes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709060:Modulator [Manufactured Object]

Phrase: "and"

Phrase: "a number of important roles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "emerged"

Phrase: "implicating"

Phrase: "it in a wide spectrum of cardiovascular disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007222:Cardiovascular disease [Disease or Syndrome]
   744   C0007226:Cardiovascular [Body System]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0332464:Wide [Spatial Concept]
   744   C1883073:Spectrum [Quantitative Concept]
   744   C2827424:Spectrum [Conceptual Entity]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.25: NO represents a biological "double-edged sword" with both established roles in cellular cytotoxicity and also emerging roles in cytoprotection. 

Phrase: "NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a biological ""double-edged sword"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0522656:Sword [Manufactured Object]

Phrase: "with both established roles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0035820:Roles [Social Behavior]
   827 E C1705810:Role [Conceptual Entity]

Phrase: "in cellular cytotoxicity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0301896:Cellular Cytotoxicity [Cell Function]
   861   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   789 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   789 E C1511636:cytotoxic [Functional Concept]

Phrase: "and"

Phrase: "also emerging roles in cytoprotection."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]
Processing 00000000.tx.26: Described mechanisms for NO-mediated cytoprotection include antiapoptotic (14), antioxidant (30), anti-inflammatory (15), and cGMP-mediated effects (8). 

Phrase: "Described mechanisms for NO-mediated cytoprotection"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "antiapoptotic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986514:antiapoptotic [Chemical Viewed Functionally]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "antioxidant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidant [Pharmacologic Substance]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "anti-inflammatory"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003209:Anti-inflammatory [Pharmacologic Substance]
  1000   C1515999:Anti-inflammatory [Qualitative Concept]
   861   C0333348:Inflammatory [Functional Concept]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cGMP-mediated effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.27: More recently, a body of experimental evidence in rabbits has implicated NO as a trigger and mediator of late preconditioning (PC) against stunning and myocardial infarction (2, 4, 27, 33). 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "a body of experimental evidence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]

Phrase: "in rabbits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: "has"

Phrase: "implicated NO as a trigger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0030015:oxide [Inorganic Chemical]
   753   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "mediator of late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "preconditioning"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "("

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: ")"

Phrase: "against stunning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0009676:Dazed [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "myocardial infarction"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0027051:Myocardial Infarction [Disease or Syndrome]
  1000   C0428953:MYOCARDIAL INFARCTION [Finding]
  1000   C2926063:Myocardial infarction [Clinical Attribute]
   861   C0021308:Infarction [Pathologic Function]
   861   C0027061:Myocardial [Tissue]
   861   C1522564:Myocardial [Spatial Concept]
   789 E C0333541:Infarcted [Functional Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4,"

Phrase: "27,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.28: The mechanism of protection appears to be antioxidant sensitive (34) and inducible (i) nitric oxide synthase (NOS; see Ref. 12) and protein kinase C (PKC) dependent (26). 

Phrase: "The mechanism of protection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "antioxidant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidant [Pharmacologic Substance]

Phrase: "sensitive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332324:Sensitive [Functional Concept]
  1000   C1550474:sensitive [Idea or Concept]

Phrase: "(34"

Phrase: ")"

Phrase: "and"

Phrase: "inducible (i) nitric oxide synthase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
  1000   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(NOS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "protein kinase C (PKC)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.29: Earlier studies have implicated NO in early PC against pacing-induced arrhythmias in the canine heart (37) and reperfusion-induced arrhythmias in the rat heart (1), but a role for NO against lethal myocardial injury in early PC remains unclear. 

Phrase: "Earlier studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "implicated NO in early"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0030015:oxide [Inorganic Chemical]
   760   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "PC against pacing-induced arrhythmias"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0003811:Arrhythmias [Pathologic Function]
   760   C0205263:Induced [Functional Concept]
   760   C0562458:Pacing [Individual Behavior]
   760   C0871117:Preconditioning [Mental Process]
   726 E C0287990:PACE [Amino Acid, Peptide, or Protein,Enzyme]
   726 E C1552930:Pace [Quantitative Concept]
   726 E C1709632:Precondition [Conceptual Entity]

Phrase: "in the canine heart"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "(37"

Phrase: ")"

Phrase: "and"

Phrase: "reperfusion-induced arrhythmias in the rat heart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0003811:Heart Arrhythmias [Pathologic Function]
           Arrhythmias
   774   C0853339:reperfusion arrhythmias [Pathologic Function]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "a role for NO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "against lethal myocardial injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0746730:myocardial injury [Injury or Poisoning]
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]

Phrase: "in early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "remains"

Phrase: "unclear."
Processing 00000000.tx.30: The purpose of this investigation was to determine whether NO was implicated in protection using an established model of early PC in cultured neonatal rat cardiocytes (41). 

Phrase: "The purpose of this investigation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1285529:Purpose [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "was"

Phrase: "implicated in protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1545588:Protection [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an established model of early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "PC in cultured neonatal rat cardiocytes"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0871117:Preconditioning [Mental Process]
   753   C1552240:Neonatal [Professional or Occupational Group]
   753   C1552264:Neonatal [Professional or Occupational Group]
   753   C2939425:Neonatal [Temporal Concept]
   719   C0225828:Cardiocyte [Cell]
   719 E C1709632:Precondition [Conceptual Entity]
   719   C2333889:Cardiocyte [Classification]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.31: This model shares many of the features of PC in vivo and has the additional benefit of low nonmyocyte (<5%) contamination, enhancing data interpretation. 

Phrase: "This model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "many of the features of"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0439064:Many [Quantitative Concept]
   760   C0747726:many [Conceptual Entity]
   726   C1521970:Feature [Qualitative Concept]
   726   C1706388:Feature [Conceptual Entity]
   726   C2346469:Feature [Qualitative Concept]
   726   C2348519:Feature [Qualitative Concept]

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "has"

Phrase: "the additional benefit of low nonmyocyte"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0814225:Benefit [Quantitative Concept]

Phrase: "("

Phrase: "<5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "contamination,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0259846:contamination [Human-caused Phenomenon or Process]
  1000   C1881659:CONTAMINATION [Event]
  1000   C2349974:Contamination [Idea or Concept]

Phrase: "enhancing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2349975:Enhance [Activity]

Phrase: "data interpretation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0459471:Interpretation [Intellectual Product]
   861   C1511726:Data [Idea or Concept]
   861   C3173575:Interpretation [Clinical Attribute]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.32: Therefore, our aim was to use this model to determine the role and interrogate the mechanisms of NO-mediated cardioprotection.  

Phrase: "Therefore,"

Phrase: "our aim"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1947946:Aim [Idea or Concept]
  1000   C2948600:Aim [Pharmacologic Substance]
  1000   C3540471:AIM [Gene or Genome]
  1000   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "this model to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "determine"

Phrase: "the role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "interrogate"

Phrase: "the mechanisms of NO-mediated cardioprotection."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.33: METHODS TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Materials DMEM, medium 199(M199), BSA, horse serum, FCS, pancreatin, and penicillin/streptomycin were from Life Technologies. 

Phrase: "METHODS TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials DMEM,"

Phrase: "medium 199"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "(M199"

Phrase: ")"

Phrase: ","

Phrase: "BSA,"

Phrase: "horse serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1518416:Serum, Horse [Immunologic Factor]
   861   C0019944:Horse [Mammal]
   861   C0229671:Serum [Body Substance]
   861   C0242616:Horse [Mammal]
   861   C1265527:Horse [Mammal]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "FCS,"

Phrase: "pancreatin,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0030304:Pancreatin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   944 E C0702059:Viokase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   944 E C0733536:Panteric [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "penicillin/streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "were from Life Technologies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0039421:technologies [Occupation or Discipline]
   770   C0376558:Life [Idea or Concept]
Processing 00000000.tx.34: Collagenase was from Worthington. 

Phrase: "Collagenase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "was from Worthington."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.35: HEPES was from Sigma (Poole, UK). 

Phrase: "HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was from Sigma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
   790   C1719918:Sigma [Intellectual Product]

Phrase: "(Poole,"

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.36: S-nitroso-N-acetyl-L,L-penicillamine (SNAP), NG-monomethyl-L-arginine monoacetate (L-NMMA), and 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) were obtained from Calbiochem. 

Phrase: "S-nitroso-N-acetyl-L,L-penicillamine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   740 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "("

Phrase: "SNAP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   740 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "NG-monomethyl-L-arginine monoacetate (L-NMMA),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0069477:NG-Monomethyl-L-Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "1H-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "[1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4"

Phrase: "]oxadiazolo"

Phrase: "[4,"

Phrase: "3-a]quinoxalin-1-one (ODQ)"

Phrase: "were"

Phrase: "obtained from Calbiochem."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.37: Dexamethasone, chelerythrine, and 5-hydroxydecanoate (5-HD) were obtained from Sigma-Aldrich (Gillingham, UK). 

Phrase: "Dexamethasone,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "chelerythrine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0055278:chelerythrine [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "5-hydroxydecanoate (5-HD)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0098450:5-hydroxydecanoate [Lipid,Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained from Sigma-Aldrich"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1301820:Obtained [Functional Concept]
   770   C1719918:Sigma [Intellectual Product]
   737 E C1706701:Obtain [Activity]

Phrase: "(Gillingham,"

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.38: Glibenclamide was obtained from ICN Pharmaceuticals (Basingstoke, UK). 

Phrase: "Glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "obtained from ICN Pharmaceuticals"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0331834:ICN Pharmaceuticals [Health Care Related Organization]
   770   C1135440:Pharmaceuticals [Therapeutic or Preventive Procedure]
   770   C1254351:Pharmaceuticals [Pharmacologic Substance]
   770   C1301820:Obtained [Functional Concept]
   737 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   737 E C1706701:Obtain [Activity]

Phrase: "(Basingstoke,"

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.39: Rabbit polyclonal iNOS/NOS type II antibody was obtained from Transduction Laboratories (Exeter, UK). 

Phrase: "Rabbit polyclonal iNOS/NOS type II antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   890   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   881   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   787   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   787   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "obtained from Transduction Laboratories"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0022877:Laboratories [Manufactured Object,Organization]
   770   C1160185:transduction [Organism Function]
   770   C1301820:Obtained [Functional Concept]
   770   C1619828:Laboratories [Intellectual Product]
   737 E C1706701:Obtain [Activity]
   737 E C3244292:laboratory [Functional Concept]

Phrase: "(Exeter,"

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.40: Peroxidase-conjugated anti-rabbit immunoglobulins were from DAKO (High Wycombe, UK). 

Phrase: "Peroxidase-conjugated anti-rabbit immunoglobulins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0021027:Immunoglobulins [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0202081:Immunoglobulins NOS [Laboratory Procedure]
   771 E C1621846:immunoglobulin [Molecular Function]

Phrase: "were from DAKO"

Phrase: "(High Wycombe,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.41: Isolation and Culture of Rat Ventricular Cardiomyocytes Neonatal rat ventricular cardiomyocytes were prepared from 1-to 2-day-old Sprague-Dawley rats, as described previously (7). 

Phrase: "Isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "Culture of Rat Ventricular Cardiomyocytes Neonatal rat ventricular cardiomyocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0010453:Culture [Idea or Concept]
   742   C0220814:culture [Functional Concept]
   742   C0430400:Culture [Laboratory Procedure]
   742   C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "prepared from 1-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1521827:Prepare [Functional Concept]

Phrase: "to 2-day-old Sprague-Dawley rats,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0034715:Rats, Sprague-Dawley [Mammal]
   827   C2699239:Sprague-Dawley [Mammal]
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.42: Briefly, cells from neonatal rat ventricles were dispersed in a series of incubations at 37C in HEPES-buffered salt solution containing 0.6mg/ml pancreatin and 0.5mg/ml collagenase. 

Phrase: "Briefly,"

Phrase: "cells from neonatal rat ventricles"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "dispersed in a series of incubations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205549:Series [Quantitative Concept]
   753   C0332624:Dispersed [Spatial Concept]
   753   C2348044:Series [Intellectual Product]

Phrase: "at 37C"

Phrase: "in HEPES-buffered salt solution"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0036140:Salt [Chemical Viewed Structurally]
   812   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0037633:Solution [Substance]
   812   C0206136:Salt [Food,Inorganic Chemical]
   812   C0525069:Solution [Biomedical or Dental Material]
   741 E C1537053:salty [Qualitative Concept]
   712 E C0678584:saltiness [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.6mg/ml pancreatin"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0030304:Pancreatin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   756 E C0702059:Viokase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   756 E C0733536:Panteric [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.5mg/ml collagenase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
Processing 00000000.tx.43: The dispersed cells were preplated for at least 30min to minimize fibroblast contamination, and the unattached cells were replated on six-well gelatin-coated plates at a density of 1-1.5106 cells/well. 

Phrase: "The dispersed cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preplated for"

Phrase: "at least 30min to"

Phrase: "minimize"

Phrase: "fibroblast contamination,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0259846:contamination [Human-caused Phenomenon or Process]
   861   C1881659:CONTAMINATION [Event]
   861   C2349974:Contamination [Idea or Concept]

Phrase: "and"

Phrase: "the unattached cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "replated on six-well gelatin-coated plates"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   748   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   748   C0205170:Well [Qualitative Concept]
   748   C0205452:Six [Quantitative Concept]
   748   C1139930:plates [Medical Device]
   748   C1145617:Gelatin [Food]
   748   C1522408:Coated [Qualitative Concept]
   748   C3146287:Well [Manufactured Object]
   714 E C0005971:Plate [Medical Device]
   714 E C0453946:Coat [Manufactured Object]
   714 E C2987482:Coat [Body Part, Organ, or Organ Component]
   714 E C3537155:Plate [Manufactured Object]

Phrase: "at a density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "of 1-1.5106 cells/well."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   840   C2347578:Cells/well [Quantitative Concept]
   804   C0007634:Cells [Cell]
   804   C0205170:Well [Qualitative Concept]
   804   C2827734:1+ [Quantitative Concept]
   804   C2981698:1+ [Classification]
   804   C3146287:Well [Manufactured Object]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.44: Fibroblast contamination was <5%. 

Phrase: "Fibroblast contamination"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0259846:contamination [Human-caused Phenomenon or Process]
   861   C1881659:CONTAMINATION [Event]
   861   C2349974:Contamination [Idea or Concept]

Phrase: "was <"

Phrase: "5%."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.45: The cardiac myocytes were cultured at 37C in room air with 5% CO2 in 4:1 DMEM-M199 supplemented with 10% horse serum, 5% FCS, and 100U/ml penicillin-streptomycin for the first 24h. 

Phrase: "The cardiac myocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0225828:Myocytes, Cardiac [Cell]
   861   C0596981:Myocytes [Cell]

Phrase: "were"

Phrase: "cultured at 37C in room air"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0001861:Air [Substance]
   753   C1547703:Room [Spatial Concept]
   753   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "with 5% CO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "in 4"

Phrase: ":"

Phrase: "1 DMEM-M199"

Phrase: "supplemented with 10% horse serum,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C1518416:Serum, Horse [Immunologic Factor]
   760   C0019944:Horse [Mammal]
   760   C0229671:Serum [Body Substance]
   760   C0242616:Horse [Mammal]
   760   C1265527:Horse [Mammal]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "5% FCS,"

Phrase: "and"

Phrase: "100U/ml penicillin-streptomycin for the first 24h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0038425:Streptomycin [Antibiotic,Carbohydrate]
Processing 00000000.tx.46: Thereafter, cells were maintained in an identical medium with a reduced serum concentration of 1% FCS. 

Phrase: "Thereafter,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained in an identical medium"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0009458:Medium [Intellectual Product]
   760   C0205280:Identical [Qualitative Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C1314677:Maintained [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726 E C0024501:Maintain [Activity]

Phrase: "with a reduced serum concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   913   C0424099:Reduced concentration [Finding]
   901   C0683149:serum concentration [Quantitative Concept]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 1% FCS."
Processing 00000000.tx.47: Under these conditions, an excess of 80% of cells were beat spontaneously for the duration of the experiment. 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "an excess of 80% of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1979886:Excess [Qualitative Concept]

Phrase: "were"

Phrase: "beat"

Phrase: "spontaneously for the duration of the experiment."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0449238:Duration [Temporal Concept]
   748   C0681814:Experiment [Research Activity]
   748   C1706386:Experiment [Conceptual Entity]
   748   C2926735:Duration [Pharmacologic Substance]
Processing 00000000.tx.48: Experiments were performed after 2days in culture. 

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed after 2days"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in culture."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.49: Simulated Ischemia Model Cells were washed with PBS before addition of 1ml ischemia buffer (in mM: 118NaCl, 24NaHCO3, 1NaH2PO4 H2O, 2.5CaCl2 2H2O, 1.2MgCl2, 0.5sodium EDTA 2H2O, 20sodium lactate, and 16KCl, pH 6.2). 

Phrase: "Simulated Ischemia Model Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with PBS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "before addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 1ml ischemia buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "("

Phrase: "in mM"

Phrase: ":"

Phrase: "118NaCl,"

Phrase: "24NaHCO3,"

Phrase: "1NaH2PO4 H2O,"

Phrase: "2.5CaCl2 2H2O,"

Phrase: "1.2MgCl2,"

Phrase: "0.5sodium EDTA 2H2O,"

Phrase: "20sodium lactate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022924:lactate [Organic Chemical]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "16KCl,"

Phrase: "pH 6.2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.50: Near-anoxic conditions were achieved by one of two methods. 

Phrase: "Near-anoxic conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "achieved by one of two methods."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0025663:Methods [Intellectual Product]
   753   C0025664:methods [Intellectual Product]
   753   C0205447:One [Quantitative Concept]
   753   C0205448:Two [Quantitative Concept]
   753   C0449851:Methods [Functional Concept]
   719 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.51: In the PC experiments, after pregassing with 95% argon-5% CO2, the ischemia buffer was added to the cells, which were then placed in a purpose-built ischemia chamber and incubated at 37C in 95% argon-5% CO2 The O2 content of the atmosphere inside the chamber was <1% for the duration of the experiment, as measured by an on-line meter (Griffin and George, Fife, UK). 

Phrase: "In the"

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "after"

Phrase: "pregassing with 95% argon-5% CO2,"

Phrase: "the ischemia buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "added to the cells,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1524062:Added [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1883712:Add [Functional Concept]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "placed in a purpose-built ischemia chamber"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0022116:Ischaemia [Disease or Syndrome]
   748   C0935616:Chamber [Body Part, Organ, or Organ Component]
   748   C1285529:Purpose [Functional Concept]
   714   C0442504:Place [Spatial Concept]
   714   C1704765:Place [Functional Concept]
   714   C1707059:Build [Conceptual Entity]
   714   C1882509:Place [Activity]
   714   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "in 95% argon-5% CO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "The O2 content of the atmosphere"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "inside the chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "was <"

Phrase: "1% for the duration of the experiment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0449238:Duration [Temporal Concept]
   748   C0681814:Experiment [Research Activity]
   748   C1706386:Experiment [Conceptual Entity]
   748   C2827734:1+ [Quantitative Concept]
   748   C2926735:Duration [Pharmacologic Substance]
   748   C2981698:1+ [Classification]

Phrase: "as"

Phrase: "measured by an on-line meter"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0205132:Line [Spatial Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C0475209:Meter [Quantitative Concept]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   753   C1706378:METER [Manufactured Object]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "(Griffin"

Phrase: "and"

Phrase: "George,"

Phrase: "Fife,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454909:Fife [Geographic Area]

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.52: Subsequent experiments were performed using the BBL GasPak Pouch System (Becton-Dickinson). 

Phrase: "Subsequent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BBL GasPak Pouch System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(Becton-Dickinson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.53: This system provides a compact microenvironment contained in an impermeable bag that, when properly activated and sealed, provides anaerobic conditions with an O2 concentration of <2% within 2h of incubation at 35C. 

Phrase: "This system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a compact microenvironment"

Phrase: "contained in an impermeable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332256:contained [Functional Concept]
   770   C2700400:Contained [Activity]

Phrase: "bag"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0179196:Bag [Manufactured Object]
  1000   C1704776:Bag [Manufactured Object]

Phrase: "that,"

Phrase: "when"

Phrase: "properly"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "sealed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0036492:Seal [Mammal]
   966   C0325125:seal [Mammal]
   966   C1704637:Seal [Manufactured Object]

Phrase: ","

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "anaerobic conditions with an O2 concentration of <2%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0012634:condition [Disease or Syndrome]
   711   C0348080:Condition [Qualitative Concept]
   711   C1705253:Condition [Conceptual Entity]

Phrase: "within 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "of incubation"

Phrase: "at 35C."
Processing 00000000.tx.54: First, the liquid-activating reagent (containing 5g of the following: iron powder, calcium carbonate, citric acid, and inert extender) is placed in the reagent channel of the GasPak Pouch. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the liquid-activating reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(containing 5g of the following"

Phrase: ":"

Phrase: "iron powder,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032861:Powder [Biomedical or Dental Material]
   861   C1382110:Powder [Substance]

Phrase: "calcium carbonate,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0006681:Calcium Carbonate [Inorganic Chemical,Pharmacologic Substance]
   861   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0006726:Calcium [Inorganic Chemical]
   861   C0007026:Carbonate [Inorganic Chemical]
   861   C2936886:Calcium [Pharmacologic Substance]

Phrase: "citric acid,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0055819:Citric Acid [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
           citric
  1000   C1171556:citric acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "inert extender"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707980:Extender [Manufactured Object]

Phrase: ")"

Phrase: "is"

Phrase: "placed in the reagent channel of the GasPak Pouch."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   742   C0439799:Channel [Spatial Concept]
   742   C1553454:Pouch [Intellectual Product]
   742   C1706095:Channel [Conceptual Entity]
   742   C1706199:POUCH [Manufactured Object]
   708   C0442504:Place [Spatial Concept]
   708   C1704765:Place [Functional Concept]
   708   C1882509:Place [Activity]
   708   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.55: Next, the 6-or 12-well plate is heat-sealed within the bag. 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "the 6-"

Phrase: "or"

Phrase: "12-well plate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005971:Plate [Medical Device]
   827   C1139930:plate [Medical Device]
   827   C3537155:Plate [Manufactured Object]

Phrase: "is"

Phrase: "heat-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "sealed within the bag."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0179196:Bag [Manufactured Object]
   770   C1704776:Bag [Manufactured Object]
   737   C0036492:Seal [Mammal]
   737   C0325125:seal [Mammal]
   737   C1704637:Seal [Manufactured Object]
Processing 00000000.tx.56: The catalytic reaction that ensues consumes O2 and produces CO2. 

Phrase: "The catalytic reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "that"

Phrase: "ensues"

Phrase: "consumes"

Phrase: "O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "produces"

Phrase: "CO2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.57: An anaerobic strip on the surface of the bag turns from blue to white once anoxic conditions are achieved. 

Phrase: "An anaerobic strip on the surface of the bag"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1321564:Strip [Medical Device]

Phrase: "turns from blue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0541749:Turns [Finding]
   790   C1260957:Blue [Qualitative Concept]
   790   C1709743:Turn [Spatial Concept]

Phrase: "to white once anoxic conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: "are"

Phrase: "achieved."
Processing 00000000.tx.58: Both methods for producing hypoxia after 6h incubation at 37C in 95% air-5% CO2 produced ~50% cell death in control cells. 

Phrase: "Both methods for producing hypoxia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0449851:Methods [Functional Concept]
   726 E C0871511:METHOD [Intellectual Product]

Phrase: "after 6h incubation"

Phrase: "at 37C"

Phrase: "in 95% air-5% CO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "produced"

Phrase: "~50% cell death in control cells."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0007587:Cell Death [Cell Function]
           cells death
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.59: Evaluation of Cell Viability Cell viability was quantified using 3-4,5-di-methylthiazol-2-yl-2,5-diphenyltetrazolium bromide (MTT) bioreduction assay (23). 

Phrase: "Evaluation of Cell Viability Cell viability"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C2984640:CELL EVALUATION [Functional Concept]
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "was"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "3-4,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442757:3 4 [Finding]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "5-di-methylthiazol-2-yl-2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0439084:>5 [Quantitative Concept]
   799   C0728893:+5 [Quantitative Concept]
   799   C3538902:DI [Gene or Genome]
   799   C3541881:DI [Idea or Concept]

Phrase: "5-diphenyltetrazolium bromide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006222:Bromide [Inorganic Chemical]

Phrase: "(MTT) bioreduction assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C2986858:MTT Assay [Research Activity]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.60: Briefly, cell culture plates were washed with PBS, exposed to 5mg/ml of MTT solution, and placed in an incubator at 37C for 20-30 min. 

Phrase: "Briefly,"

Phrase: "cell culture plates"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0180454:culture plates [Medical Device]
   896   C1166718:cell plate [Cell Component]
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]
   734   C0007585:Cell Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "washed with PBS,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "exposed to 5mg/ml of MTT solution,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0332157:Exposed to [Clinical Attribute]
           Exposed
   748   C0037633:Solution [Substance]
   748   C0439526:/mL [Quantitative Concept]
   748   C0525069:Solution [Biomedical or Dental Material]
   748   C0647210:mtt [Lipid]

Phrase: "and"

Phrase: "placed in an incubator"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0021178:Incubator [Manufactured Object]
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]

Phrase: "at 37C"

Phrase: "for 20-30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0456693:/30 min [Temporal Concept]
   901   C1442458:30 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]
Processing 00000000.tx.61: The dark blue crystals that formed were dissolved in stop solution containing 0.1M HCl, 10% Triton X-100, and isopropanol, and the absorbance was read at 570-nm wavelength. 

Phrase: "The dark blue crystals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0427896:Crystals [Body Substance]
   827   C0444626:Crystals [Chemical Viewed Structurally]
   827   C1378554:Crystals [Biomedical or Dental Material]
   827   C1533132:Crystals [Body Substance]
   827   C2699477:Crystals [Laboratory Procedure]
   793 E C1704641:Crystal [Manufactured Object]

Phrase: "that"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "dissolved in stop solution"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0037633:Solution [Substance]
   770   C0525069:Solution [Biomedical or Dental Material]
   770   C1947925:Stop [Activity]
   770   C2746065:Stop [Temporal Concept]
   737   C1549535:Dissolve [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1M HCl,"

Phrase: "10% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "isopropanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022237:Isopropanol [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "the absorbance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1268822:Absorbance [Clinical Attribute]
  1000   C2825050:Absorbance [Phenomenon or Process]

Phrase: "was"

Phrase: "read at 570-nm wavelength."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034754:Read [Daily or Recreational Activity]
   760   C0312860:NM [Cell Function]
   760   C0449819:Wavelength [Quantitative Concept]
   760   C1705179:read [Finding]
Processing 00000000.tx.62: Measurement of Lactate Dehydrogenase Activity After the end of simulated ischemia, buffer was gently aspirated and saved for lactate dehydrogenase (LDH) determination. 

Phrase: "Measurement of Lactate Dehydrogenase Activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0202113:Lactate dehydrogenase measurement [Laboratory Procedure]
   797   C0202115:Lactate measurement [Laboratory Procedure]
   760   C0242485:Measurement [Functional Concept]

Phrase: "After the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of simulated ischemia,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0022116:Ischaemia [Disease or Syndrome]
   861   C0284447:simulated [Biomedical or Dental Material]
   789 E C0475224:Ischaemic [Functional Concept]
   789 E C0679083:Simulation [Research Activity]

Phrase: "buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "gently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1638411:Gently [Qualitative Concept]

Phrase: "aspirated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0700198:Aspirated [Pathologic Function]
   966 E C0370199:Aspirate [Body Substance]

Phrase: "and"

Phrase: "saved for lactate dehydrogenase (LDH) determination."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0022924:lactate [Organic Chemical]
   760   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   760   C1148554:determination [Laboratory Procedure]
   726   C2347840:Save [Machine Activity]
Processing 00000000.tx.63: A spectrophotometric LDH enzyme assay was performed with a Sigma assay kit (TOX-7; see Ref. 16). 

Phrase: "A spectrophotometric LDH enzyme assay"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   840   C2717977:Enzyme Assay [Laboratory Procedure]
   804   C0005507:Assay [Laboratory Procedure]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0243073:assay [Qualitative Concept]
   804   C1510438:Assay [Laboratory Procedure]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "performed with a Sigma assay kit (TOX-7"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   744   C0005507:Assay [Laboratory Procedure]
   744   C0040541:TOX [Biomedical Occupation or Discipline]
   744   C0243073:assay [Qualitative Concept]
   744   C0600688:TOX [Injury or Poisoning]
   744   C0812225:KIT [Medical Device]
   744   C0884358:Performed [Functional Concept]
   744   C1150635:KIT [Molecular Function]
   744   C1510438:Assay [Laboratory Procedure]
   744   C1705212:Kit [Medical Device]
   744   C1705213:KIT [Medical Device]
   744   C1719918:Sigma [Intellectual Product]
   744   C1847320:TOX [Gene or Genome]
   744   C3273202:Kit [Manufactured Object]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.64: Experimental Protocols In all experiments, cell viability was assessed by MTT bioreduction and LDH release at the end of lethal ischemia (Fig. 1). 

Phrase: "Experimental Protocols In all experiments,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0442711:Protocols [Intellectual Product]
   726 E C1507394:Protocol [Intellectual Product]
   726 E C1522729:Protocol [Intellectual Product]
   726 E C2348563:Protocol [Intellectual Product]

Phrase: "cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "assessed by MTT bioreduction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0647210:mtt [Lipid]
   770   C1516048:Assessed [Activity]

Phrase: "and"

Phrase: "LDH release at the end of lethal ischemia"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0030685:Release [Health Care Activity]
   742   C0391871:Release [Functional Concept]
   742   C0439180:% release [Quantitative Concept]
   742   C0680255:release [Health Care Activity]
   742   C1283071:Release [Functional Concept]
   742   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.65: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.66: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.67: Experimental protocols. 

Phrase: "Experimental protocols."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.68: The following experiments were performed on neonatal rat ventricular myocytes in primary culture. 

Phrase: "The following experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed on neonatal rat ventricular myocytes"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   756   C2339371:Ventricular myocyte [Cell]
   753   C0018827:Ventricular [Body Part, Organ, or Organ Component]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0596981:Myocytes [Cell]
   753   C0884358:Performed [Functional Concept]
   753   C1522565:Ventricular [Spatial Concept]
   753   C1552240:Neonatal [Professional or Occupational Group]
   753   C1552264:Neonatal [Professional or Occupational Group]
   753   C2939425:Neonatal [Temporal Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in primary culture."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0010453:Culture [Idea or Concept]
   861   C0205225:Primary [Qualitative Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   861   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.69: Experiment (Expt) 1represents preconditioning (PC) cells "preconditioned" with 90min of simulated ischemia (SI) before 6h SI. 

Phrase: "Experiment (Expt) 1represents"

Phrase: "preconditioning"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "("

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: ")"

Phrase: "cells """
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "preconditioned"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0871117:precondition [Mental Process]
   966   C1709632:Precondition [Conceptual Entity]

Phrase: """"

Phrase: "with 90min"

Phrase: "of simulated ischemia"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0022116:Ischaemia [Disease or Syndrome]
   861   C0284447:simulated [Biomedical or Dental Material]
   789 E C0475224:Ischaemic [Functional Concept]
   789 E C0679083:Simulation [Research Activity]

Phrase: "(SI"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022116:Ischaemia [Disease or Syndrome]
   789 E C0475224:Ischaemic [Functional Concept]

Phrase: ")"

Phrase: "before"

Phrase: "6h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292428:6H [Temporal Concept]

Phrase: "SI."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022116:Ischaemia [Disease or Syndrome]
   861   C1948023:Stimulated [Natural Phenomenon or Process]
   789 E C0475224:Ischaemic [Functional Concept]
Processing 00000000.tx.70: Expt 2shows effects of 1mM NG-monomethyl-L-arginine monoacetate (L-NMMA) and 0.1M dexamethasone on PC. 

Phrase: "Expt 2shows effects of 1mM NG-monomethyl-L-arginine monoacetate"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1280500:effects [Qualitative Concept]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "(L-NMMA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003765:L-Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "0.1M dexamethasone on PC."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   704 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   704 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   704 E C0740057:Decadron [Pharmacologic Substance,Steroid]
Processing 00000000.tx.71: Expt 3is S-nitroso-N-acetyl-L,L-penicillamine (SNAP)-induced protection cells pretreated 90min with 1mM SNAP to mimic PC before 6h SI. 

Phrase: "Expt 3is"

Phrase: "S-nitroso-N-acetyl-L,L-penicillamine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   740 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "("

Phrase: "SNAP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   740 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")-"

Phrase: "induced protection cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "pretreated"

Phrase: "90min with 1mM"

Phrase: "SNAP to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   850   C0439394:s l [Quantitative Concept]
   793   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   793   C2603362:S' [Clinical Attribute]
   737 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "mimic"

Phrase: "PC before 6h"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0871117:Preconditioning [Mental Process]
   790   C1292428:6H [Temporal Concept]
   756 E C1709632:Precondition [Conceptual Entity]

Phrase: "SI."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022116:Ischaemia [Disease or Syndrome]
   861   C1948023:Stimulated [Natural Phenomenon or Process]
   789 E C0475224:Ischaemic [Functional Concept]
Processing 00000000.tx.72: Expt 4shows effects of 10M 1H[1,2,4]oxadiazolo- [4,3]quinoxalin-1-one (ODQ), 2M chelerythrine, 10M glibenclamide, and 100M 5-hydroxydecanoate (5-HD) on SNAP-induced protection. 

Phrase: "Expt 4shows effects of 10M 1H"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "[1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4"

Phrase: "]oxadiazolo-"

Phrase: "[4,"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "]quinoxalin-1-one (ODQ"

Phrase: ")"

Phrase: ","

Phrase: "2M chelerythrine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0055278:chelerythrine [Organic Chemical,Pharmacologic Substance]

Phrase: "10M glibenclamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "100M 5-hydroxydecanoate"

Phrase: "(5-HD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0098450:5-hydroxydecanoate [Lipid,Pharmacologic Substance]

Phrase: ")"

Phrase: "on SNAP-induced protection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1545588:Protection [Finding]
Processing 00000000.tx.73: Cell viability was assessed by MTT activation and of LDH release at end of 6h SI, as described in METHODS. 

Phrase: "Cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "assessed by MTT activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0647210:mtt [Lipid]
   770   C1516048:Assessed [Activity]
   770   C1879547:Activation [Activity]

Phrase: "and of LDH release"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0022924:lactate [Organic Chemical]
   760   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0030685:Release [Health Care Activity]
   760   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1515981:And [Idea or Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "at end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of 6h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292428:6H [Temporal Concept]

Phrase: "SI,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022116:Ischaemia [Disease or Syndrome]
   861   C1948023:Stimulated [Natural Phenomenon or Process]
   789 E C0475224:Ischaemic [Functional Concept]

Phrase: "as"

Phrase: "described in METHODS."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.74: Isch, ischemia; 

Phrase: "Isch,"

Phrase: "ischemia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022116:Ischaemia [Disease or Syndrome]
   928 E C0475224:Ischaemic [Functional Concept]

Phrase: ";"
Processing 00000000.tx.75: Dex, dexamethasone; 

Phrase: "Dex,"

Phrase: "dexamethasone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: ";"
Processing 00000000.tx.76: R, reperfusion; 

Phrase: "R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "reperfusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035124:Reperfusion [Therapeutic or Preventive Procedure]
  1000   C0684253:reperfusion [Biologic Function]

Phrase: ";"
Processing 00000000.tx.77: MTT, 34,5-dimethylthiazol-2yl-2,5-diphenyltetrazolium bromide; 

Phrase: "MTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0647210:mtt [Lipid]

Phrase: "34,"

Phrase: "5-dimethylthiazol-2yl-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: "5-diphenyltetrazolium bromide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006222:Bromide [Inorganic Chemical]

Phrase: ";"
Processing 00000000.tx.78: LDH, lactate dehydrogenase. 

Phrase: "LDH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "lactate dehydrogenase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.79: Experiment 1: PC. 

Phrase: "Experiment 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: ":"

Phrase: "PC."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]
Processing 00000000.tx.80: Lethal ischemia was simulated by subjecting the cells to 6h of simulated ischemia (SI) using either the hypoxia chamber or GasPak Pouches. 

Phrase: "Lethal ischemia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022116:Ischaemia [Disease or Syndrome]
   789 E C0475224:Ischaemic [Functional Concept]

Phrase: "was"

Phrase: "simulated by subjecting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0284447:simulated [Biomedical or Dental Material]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "the cells to 6h of simulated ischemia"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   762   C0007634:THE CELL [Cell]
           Cells
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(SI"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022116:Ischaemia [Disease or Syndrome]
   789 E C0475224:Ischaemic [Functional Concept]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either"

Phrase: "the hypoxia chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "GasPak Pouches."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1553454:Pouch [Intellectual Product]
   827   C1706199:POUCH [Manufactured Object]
Processing 00000000.tx.81: Cells were "preconditioned" with 90min of ischemia followed by 30-min "reperfusion" in normal maintenance medium before 6h of SI. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: """"

Phrase: "preconditioned"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0871117:precondition [Mental Process]
   966   C1709632:Precondition [Conceptual Entity]

Phrase: """"

Phrase: "with 90min"

Phrase: "of ischemia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022116:Ischaemia [Disease or Syndrome]
   928 E C0475224:Ischaemic [Functional Concept]

Phrase: "followed by 30-min ""reperfusion"""
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332283:Followed by [Temporal Concept]
           followed
   806   C0456693:/30 min [Temporal Concept]
   806   C1442458:30 min [Temporal Concept]
   760   C0035124:Reperfusion [Therapeutic or Preventive Procedure]
   760   C0684253:reperfusion [Biologic Function]
   760   C0702093:/min [Temporal Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "in normal maintenance medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "before 6h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292428:6H [Temporal Concept]

Phrase: "of SI."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022116:Ischaemia [Disease or Syndrome]
   789 E C0475224:Ischaemic [Functional Concept]
Processing 00000000.tx.82: Experiment 2: Effects of L-NMMA and dexamethasone on PC. 

Phrase: "Experiment 2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: ":"

Phrase: "Effects of L-NMMA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "dexamethasone on PC."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   734 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   734 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   734 E C0740057:Decadron [Pharmacologic Substance,Steroid]
Processing 00000000.tx.83: The effects of L-NMMA (1mM) and dexamethasone (0.1M) on PC were studied. 

Phrase: "The effects of L-NMMA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "(1mM"

Phrase: ")"

Phrase: "and"

Phrase: "dexamethasone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "(0.1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470296:1M [Quantitative Concept]

Phrase: ")"

Phrase: "on"

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "were"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.84: At this concentration, dexamethasone has previously been shown to completely inhibit iNOS mRNA expression in rat neonatal cardiocytes (35). 

Phrase: "At this concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "dexamethasone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "iNOS mRNA expression in rat neonatal cardiocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1515670:mRNA Expression [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.85: L-NMMA was given during PC ischemia, and dexamethasone pretreatment was given 1h before PC ischemia. 

Phrase: "L-NMMA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003765:L-Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "given during"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1442162:GIVEN [Conceptual Entity]
   833   C1550718:given [Idea or Concept]
   833   C3244317:given [Intellectual Product]
   799 E C1947971:Give [Functional Concept]

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "ischemia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022116:Ischaemia [Disease or Syndrome]
   928 E C0475224:Ischaemic [Functional Concept]

Phrase: "and"

Phrase: "dexamethasone pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1550147:Pretreatment [Substance]
   861   C2709094:pre treatment [Temporal Concept]
   861   C3539075:Pretreatment [Temporal Concept]
   861   C3539076:Pretreatment [Activity]

Phrase: "was"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "before"

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "ischemia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022116:Ischaemia [Disease or Syndrome]
   928 E C0475224:Ischaemic [Functional Concept]
Processing 00000000.tx.86: Experiment 3: SNAP-induced protection. 

Phrase: "Experiment 3"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: ":"

Phrase: "SNAP-induced protection."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   842   C0439394:s l [Quantitative Concept]
   791   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   791   C0205263:Induced [Functional Concept]
   791   C1545588:Protection [Finding]
   791   C2603362:S' [Clinical Attribute]
   735 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.87: Cells were exposed to 90min of SNAP (100M-2 mM) dissolved in control buffer (in mM: 118NaCl, 24NaHCO3, 1NaH2PO4 H2O, 2.5CaCl2 2H2O, 1.2MgCl2, 0.5sodium EDTA 2H2O, 20sodium pyruvate, 2D-glucose, and 10and 4KCl, pH 7.4) followed by 30min of "reperfusion" to mimic PC. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "to 90min of SNAP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   791   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   735 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(100M-2 mM)"

Phrase: "dissolved in control buffer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C1549535:Dissolve [Functional Concept]

Phrase: "("

Phrase: "in mM"

Phrase: ":"

Phrase: "118NaCl,"

Phrase: "24NaHCO3,"

Phrase: "1NaH2PO4 H2O,"

Phrase: "2.5CaCl2 2H2O,"

Phrase: "1.2MgCl2,"

Phrase: "0.5sodium EDTA 2H2O,"

Phrase: "20sodium pyruvate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034354:pyruvate [Organic Chemical]
   861   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "2D-glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "10and 4KCl,"

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "followed by 30min of ""reperfusion"" to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0035124:Reperfusion [Therapeutic or Preventive Procedure]
   753   C0684253:reperfusion [Biologic Function]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "mimic"

Phrase: "PC."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]
Processing 00000000.tx.88: The effects of 90min SNAP exposure alone (100M-2 mM) were also assessed to exclude toxicity. 

Phrase: "The effects of 90min"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "SNAP exposure"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   850   C0439394:s l [Quantitative Concept]
   793   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   793   C0274281:Exposure, NOS [Injury or Poisoning]
   793   C0332157:Exposure [Clinical Attribute]
   793   C2603362:S' [Clinical Attribute]
   737 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(100M-2 mM)"

Phrase: "were"

Phrase: "also"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.89: Experiment 4: Effects of ODQ, chelerythrine, glibenclamide, and 5-HD on SNAP-induced protection. 

Phrase: "Experiment 4"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: ":"

Phrase: "Effects of ODQ,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "chelerythrine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0055278:chelerythrine [Organic Chemical,Pharmacologic Substance]

Phrase: "glibenclamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "5-HD on SNAP-induced protection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   787   C1545588:Protection [Finding]
Processing 00000000.tx.90: The effects of the pharmacological inhibitors ODQ (10M), chelerythrine (2M), glibenclamide (10M), and 5-HD (100M) on SNAP (1mM)-induced protection were assessed. 

Phrase: "The effects of the pharmacological inhibitors ODQ (10M"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C1280500:effects [Qualitative Concept]
   717   C0728866:pharmacologic effects [Functional Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "chelerythrine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0055278:chelerythrine [Organic Chemical,Pharmacologic Substance]

Phrase: "(2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3171718:2M [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "5-HD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0098450:5-hydroxydecanoate [Lipid,Pharmacologic Substance]

Phrase: "(100M"

Phrase: ")"

Phrase: "on SNAP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   737 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(1mM"

Phrase: ")-"

Phrase: "induced protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1545588:Protection [Finding]

Phrase: "were"

Phrase: "assessed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]
Processing 00000000.tx.91: ODQ and chelerythrine were given during SNAP exposure and before long ischemia. 

Phrase: "ODQ"

Phrase: "and"

Phrase: "chelerythrine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0055278:chelerythrine [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "given during"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1442162:GIVEN [Conceptual Entity]
   833   C1550718:given [Idea or Concept]
   833   C3244317:given [Intellectual Product]
   799 E C1947971:Give [Functional Concept]

Phrase: "SNAP exposure"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   850   C0439394:s l [Quantitative Concept]
   793   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   793   C0274281:Exposure, NOS [Injury or Poisoning]
   793   C0332157:Exposure [Clinical Attribute]
   793   C2603362:S' [Clinical Attribute]
   737 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "before long ischemia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0022116:Ischaemia [Disease or Syndrome]
   755 E C0475224:Ischaemic [Functional Concept]
Processing 00000000.tx.92: The high dose of glibenclamide was chosen because previously it has been shown to block sarcolemmal ATP-dependent K+ channel activity (28) in rat ventricular cells. 

Phrase: "The high dose of glibenclamide"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0444956:High dose [Quantitative Concept]
   760   C0178602:Dose [Quantitative Concept]
   760   C0205250:High [Qualitative Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "was"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "because"

Phrase: "previously"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "sarcolemmal ATP-dependent K+ channel activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1153410:channel activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "(28"

Phrase: ")"

Phrase: "in rat ventricular cells."
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   827   C0007634:Cells [Cell]
   827   C0018827:Ventricular [Body Part, Organ, or Organ Component]
   827   C1522565:Ventricular [Spatial Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0007799:Ventricles [Body Space or Junction]
   755 E C0038351:Ventriculus [Body Part, Organ, or Organ Component]
   755 E C2355627:Ventricle [Body Part, Organ, or Organ Component]
Processing 00000000.tx.93: However, lower doses have been shown to block mitochondrial ATP-dependent K+ channels (9). 

Phrase: "However,"

Phrase: "lower doses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0178602:Doses [Quantitative Concept]
   827 E C0869039:Dose [Quantitative Concept]
   827 E C1114758:Dose # [Clinical Attribute]
   827 E C1428722:DOS [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "mitochondrial ATP-dependent K+ channels"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1701901:Dependent [Qualitative Concept]
   804   C1708601:K' [Quantitative Concept]
   804   C3244310:dependent [Functional Concept]
   771   C0439799:Channel [Spatial Concept]
   771   C1706095:Channel [Conceptual Entity]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.94: 5-HD at the dose used has been shown to specifically inhibit mitochondrial ATP-dependent K+ channel flux in isolated rat heart mitochondria (13). 

Phrase: "5-HD at the dose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0098450:5-hydroxydecanoate [Lipid,Pharmacologic Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "mitochondrial ATP-dependent K+ channel flux in isolated rat heart mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.95: Glibenclamide and 5-HD were given throughout the experimental protocol as it is currently unknown at which stage sarcolemmal/mitochondrial ATP-dependent K+ channel opening is important for protection during PC. 

Phrase: "Glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "5-HD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0098450:5-hydroxydecanoate [Lipid,Pharmacologic Substance]

Phrase: "were"

Phrase: "given throughout the experimental protocol"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0442711:Protocol [Intellectual Product]
   760   C1442162:GIVEN [Conceptual Entity]
   760   C1507394:Protocol [Intellectual Product]
   760   C1517586:Experimental [Qualitative Concept]
   760   C1522729:Protocol [Intellectual Product]
   760   C1550718:given [Idea or Concept]
   760   C2348563:Protocol [Intellectual Product]
   760   C3244317:given [Intellectual Product]
   726 E C1947971:Give [Functional Concept]

Phrase: "as"

Phrase: "it"

Phrase: "is"

Phrase: "currently unknown at which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439673:Unknown [Qualitative Concept]

Phrase: "stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "sarcolemmal/mitochondrial ATP-dependent K+ channel opening"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0175566:Opening [Spatial Concept]
   795   C1882151:Opening [Spatial Concept]

Phrase: "is"

Phrase: "important for protection"

Phrase: "during PC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
Processing 00000000.tx.96: Measurement of cGMP Levels Confluent cardiac myocyte monolayers in 24-well plates were subjected to SNAP treatment (1mM) for 90min in the presence or absence of ODQ (10M). 

Phrase: "Measurement of cGMP Levels Confluent cardiac myocyte monolayers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0588131:Cardiac measurement [Diagnostic Procedure]
   744   C0242485:Measurement [Functional Concept]

Phrase: "in 24-well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "to SNAP treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   791   C0039798:treatment [Functional Concept]
   791   C0087111:Treatment [Therapeutic or Preventive Procedure]
   791   C1522326:Treatment [Functional Concept]
   791   C1533734:Treatment [Therapeutic or Preventive Procedure]
   791   C1705169:Treatment [Conceptual Entity]
   791   C3538994:TREATMENT [Research Activity]

Phrase: "(1mM"

Phrase: ")"

Phrase: "for 90min"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of ODQ (10M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: ")."
Processing 00000000.tx.97: At the designated time, the experimental conditions were removed, and the cells were placed on ice and incubated with 0.1M HCl (500l/well, 60min). 

Phrase: "At the designated time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "the experimental conditions"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C1517586:Experimental [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "placed on ice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0020746:Ice [Inorganic Chemical]
   756   C0442504:Place [Spatial Concept]
   756   C1704765:Place [Functional Concept]
   756   C1882509:Place [Activity]
   756   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "incubated with 0.1M HCl (500l/well,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205170:Well [Qualitative Concept]
   748   C0470296:1M [Quantitative Concept]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C3146287:Well [Manufactured Object]

Phrase: "60min"

Phrase: ")."
Processing 00000000.tx.98: Cell extracts were stored at 20C for RIA of cGMP levels, as previously described (31). 

Phrase: "Cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "stored at 20C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]

Phrase: "for RIA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034580:RIA [Laboratory Procedure]

Phrase: "of cGMP levels,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0018338:cGMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.99: Western Blotting Analysis for iNOS Protein Cells undergoing a PC protocol were harvested every 30min from the beginning of PC ischemia at time points of 30,60,and 90min. 

Phrase: "Western Blotting Analysis for iNOS Protein Cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   771   C0949466:Western blot analysis [Laboratory Procedure]
   757   C1514534:Protein Analysis [Molecular Biology Research Technique]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]

Phrase: "undergoing"

Phrase: "a"

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442711:Protocol [Intellectual Product]
  1000   C1507394:Protocol [Intellectual Product]
  1000   C1522729:Protocol [Intellectual Product]
  1000   C2348563:Protocol [Intellectual Product]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "every 30min from the beginning of"

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "ischemia at time points of 30,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0022116:Ischaemia [Disease or Syndrome]

Phrase: "60,"

Phrase: "and"

Phrase: "90min."
Processing 00000000.tx.100: Cells were washed three times with PBS, harvested in 1ml of sample buffer (250mM Tris HCl, pH 6.8,4% SDS, 10% glycerol, and 2% -mercaptoethanol), and then boiled for an additional 5min. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with PBS,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "harvested in 1ml of sample buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0370003:Sample [Substance]
   753   C2347026:Sample [Conceptual Entity]
   719   C1512335:Harvest [Health Care Activity]

Phrase: "(250mM Tris HCl,"

Phrase: "pH 6.8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "4% SDS,"

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "2% -mercaptoethanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025402:2-Mercaptoethanol [Organic Chemical]
           Mercaptoethanol

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "boiled for an additional 5min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1524062:Additional [Functional Concept]
   726   C0242301:Boil [Disease or Syndrome]
   726   C1546559:Boil [Intellectual Product]
Processing 00000000.tx.101: The cell extracts were then centrifuged for 5min to remove insoluble material. 

Phrase: "The cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged for 5min to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0179834:centrifuge [Medical Device]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "insoluble material."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]
Processing 00000000.tx.102: The samples were then loaded on a 7.5% polyacrylamide gel and after one-dimensional separation were transferred to nitrocellulose membranes (Hybond C, Amersham, UK). 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "loaded on a 7.5% polyacrylamide gel"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C1382104:Gel [Substance]
   748   C1708715:Loaded [Activity]
   714 E C1550025:Load [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]

Phrase: "and after one-dimensional separation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0036679:Separation [Pathologic Function]
   760   C0205447:One [Quantitative Concept]
   760   C0237868:Separation [Social Behavior]
   760   C1515981:And [Idea or Concept]
   760   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "were"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "(Hybond C,"

Phrase: "Amersham,"

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.103: Uniform protein loading was confirmed by Coomassie staining of identically loaded gels. 

Phrase: "Uniform protein loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708715:Loading [Activity]

Phrase: "was"

Phrase: "confirmed by Coomassie staining of identically loaded gels."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   770   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   744   C0017243:Gels [Biomedical or Dental Material]
   744   C0487602:Staining [Laboratory Procedure]
   744   C0750484:Confirmed [Idea or Concept]
   744   C1704680:Staining [Finding]
   744   C1708715:Loaded [Activity]
   711 E C1382104:Gel [Substance]
   711 E C1456348:Confirm [Qualitative Concept]
   711 E C1550025:Load [Idea or Concept]
   711 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.104: The blots were probed with a rabbit polyclonal antibody specific for iNOS and a peroxidase-conjugated swine anti-rabbit IgG secondary antibody before detection with enhanced chemiluminescence (ECL, Little Chalfont, UK). 

Phrase: "The blots"

Phrase: "were"

Phrase: "probed with a rabbit polyclonal antibody"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0034493:Rabbit [Mammal]
   719   C0182400:Probe [Medical Device]
   719   C1704681:Probe [Gene or Genome]
   719   C2347609:Probe [Chemical Viewed Functionally]
   719   C3536729:Probe [Manufactured Object]

Phrase: "specific for iNOS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]
   716   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
   716   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
   716   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "a peroxidase-conjugated swine anti-rabbit IgG secondary antibody before detection"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   754   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C0368582:A Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C0430425:Antibody detection [Laboratory Procedure]
   754   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C2754943:IgG antibody [Cell Component]
   738   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   738   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "with enhanced chemiluminescence"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   861   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   861   C2349975:Enhanced [Activity]
   789 E C1627358:Enhancement [Therapeutic or Preventive Procedure]

Phrase: "(ECL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332684:ECL [Gene or Genome]

Phrase: "Little Chalfont,"

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.105: Mouse macrophage cell lysate was used as a positive control. 

Phrase: "Mouse macrophage cell lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "was"

Phrase: "used as a positive control."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C1883676:Positive Control [Conceptual Entity]
   760   C0243148:control [Qualitative Concept]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1273517:used [Finding]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825490:Positive [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.106: Statistical Analysis Data are expressed as meansSE. 

Phrase: "Statistical Analysis Data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C2828391:statistical data [Quantitative Concept]
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0871424:statistical analysis [Research Activity]

Phrase: "are"

Phrase: "expressed as meansSE."
Processing 00000000.tx.107: The n numbers refer to the number of wells from which data were obtained from at least four separate experimental preparations. 

Phrase: "The n numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "refer to the number of wells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205543:refer [Functional Concept]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]
   719   C0205170:Well [Qualitative Concept]
   719   C3146287:Well [Manufactured Object]

Phrase: "from which data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "obtained from"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   833   C1301820:Obtained [Functional Concept]
   799 E C1706701:Obtain [Activity]
   761 E C1517378:Gain [Quantitative Concept]
   740 E C0205217:Increased [Quantitative Concept]
   740 E C0439661:Acquired [Temporal Concept]
   740 E C0442805:Increase [Functional Concept]
   740 E C0442808:Increasing [Functional Concept]
   740 E C3245488:acquired [Intellectual Product]

Phrase: "at least four separate experimental preparations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0455052:Preparation [Health Care Activity]
   771   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.108: For the cell viability/LDH data, comparisons between groups were analyzed using a parametric one-way ANOVA combined with the Tukey-Kramer multiple comparisons test. 

Phrase: "For the cell viability/LDH data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1511726:Data [Idea or Concept]
   804   C3245479:data [Medical Device]

Phrase: "comparisons between groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1707455:Comparison [Activity]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a parametric one-way ANOVA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   923   C1709320:One-way ANOVA [Quantitative Concept]

Phrase: "combined with the Tukey-Kramer multiple comparisons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0205195:Combined [Qualitative Concept]
   748   C0331847:Kramer [Health Care Related Organization]
   748   C0439064:Multiple [Quantitative Concept]
   714 E C0336789:Combine [Manufactured Object]
   714   C1707455:Comparison [Activity]

Phrase: "test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]
Processing 00000000.tx.109: cGMP data were analyzed using the Kruskal-Wallis nonparametric one-way ANOVA combined with Dunn's multiple comparisons test (Graphpad Instat 1998). 

Phrase: "cGMP data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Kruskal-Wallis nonparametric one-way ANOVA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709320:One-way ANOVA [Quantitative Concept]

Phrase: "combined with Dunn's multiple comparisons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205195:Combined [Qualitative Concept]
   760   C0439064:Multiple [Quantitative Concept]
   726 E C0336789:Combine [Manufactured Object]
   726   C1707455:Comparison [Activity]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "(Graphpad Instat 1998"

Phrase: ")."
Processing 00000000.tx.110: A P value of <0.05 was considered to be statistically significant.  

Phrase: "A P value of <0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1709380:P-Value [Quantitative Concept]
   799   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "statistically significant."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.111: RESULTS TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES PC of Rat Neonatal Cardiomyocytes: Effects of L-NMMA and Dexamethasone PC with 90min of ischemia protected cardiomyocytes against subsequent 6h of lethal ischemia, resulting in a significant 28.8% increase in MTT activation and 14.5% reduction in LDH release compared with controls shown in Fig. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514811:Reference [Idea or Concept]
   760   C1706462:Reference [Conceptual Entity]

Phrase: "PC of Rat Neonatal Cardiomyocytes"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0225828:Cardiomyocytes [Cell]
   760   C0871117:Preconditioning [Mental Process]
   760   C1552240:Neonatal [Professional or Occupational Group]
   760   C1552264:Neonatal [Professional or Occupational Group]
   760   C2939425:Neonatal [Temporal Concept]
   726 E C1709632:Precondition [Conceptual Entity]

Phrase: ":"

Phrase: "Effects of L-NMMA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "Dexamethasone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "PC with 90min of ischemia protected cardiomyocytes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0022116:Ischaemia [Disease or Syndrome]
   748   C0225828:Cardiomyocytes [Cell]
   748   C0871117:Preconditioning [Mental Process]
   738   C0376466:Ischemic Preconditioning [Therapeutic or Preventive Procedure]
   714 E C1709632:Precondition [Conceptual Entity]

Phrase: "against subsequent 6h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1292428:6H [Temporal Concept]

Phrase: "of lethal ischemia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022116:Ischaemia [Disease or Syndrome]
   789 E C0475224:Ischaemic [Functional Concept]

Phrase: "resulting in a significant 28.8% increase"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0332294:Resulting in [Functional Concept]
   748   C0237881:significant [Quantitative Concept]
   748   C0442805:Increase [Functional Concept]
   748   C0678226:resulting [Functional Concept]
   748   C0750502:Significant [Idea or Concept]
   748   C1546944:Significant [Qualitative Concept]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "in MTT activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "14.5% reduction in LDH release"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.112: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.113: This protection was blocked by the nonspecific NOS inhibitor L-NMMA (1mM), causing a significant reduction in MTT activation/increase in LDH release compared with preconditioned cells. 

Phrase: "This protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "was"

Phrase: "blocked by the nonspecific NOS inhibitor L-NMMA"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   797   C1373060:Nitric Oxide Synthase Inhibitor [Pharmacologic Substance]
   797   C1744692:nitric-oxide synthase inhibitor [Molecular Function]
   775   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   756   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   738   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0028778:Blocked [Pathologic Function]
   738   C0030015:oxide [Inorganic Chemical]
   738   C0205370:Non-specific [Qualitative Concept]
   738   C0332206:Blocked [Functional Concept]
   738   C0750540:Nonspecific [Idea or Concept]
   738   C1999216:Inhibitor [Qualitative Concept]
   738   C2983591:BLOCKED [Research Activity]
   738   C2986642:oxide [Chemical Viewed Functionally]
   704 E C1533157:Block [Substance]
   704 E C1706084:Block [Geographic Area]
   704 E C2828370:Block [Quantitative Concept]

Phrase: "(1mM"

Phrase: ")"

Phrase: ","

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "a significant reduction in MTT activation/increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in LDH release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   734   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "compared with preconditioned cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737   C0871117:precondition [Mental Process]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737   C1709632:Precondition [Conceptual Entity]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.114: PC in the presence of L-NMMA was associated with an unexpected further increase in LDH release compared with controls, suggesting a worsening of ischemic injury. 

Phrase: "PC in the presence of L-NMMA"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0871117:Preconditioning [Mental Process]
   711 E C1709632:Precondition [Conceptual Entity]

Phrase: "was"

Phrase: "associated with an unexpected further increase"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0442805:Increase [Functional Concept]
   753   C1517331:Further [Spatial Concept]
   719 E C0205108:far [Spatial Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in LDH release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   734   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "compared with controls,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a worsening of ischemic injury."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0332271:Worsening [Qualitative Concept]
   760   C1457868:Worsening [Qualitative Concept]
   760   C1546960:Worsening [Idea or Concept]
   726 E C1279889:worsen [Finding]
Processing 00000000.tx.115: Dexamethasone (0.1M) pretreatment did not have any effect on PC-induced protection. 

Phrase: "Dexamethasone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "(0.1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470296:1M [Quantitative Concept]

Phrase: ")"

Phrase: "pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1550147:Pretreatment [Substance]
  1000   C2709094:pre treatment [Temporal Concept]
  1000   C3539075:Pretreatment [Temporal Concept]
  1000   C3539076:Pretreatment [Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "any effect on"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "PC-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "induced protection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1545588:Protection [Finding]
Processing 00000000.tx.116: Neither L-NMMA nor dexamethasone alone had any effect on cell viability either when given alone or after 6h of ischemia. 

Phrase: "Neither L-NMMA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003765:L-Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "nor"

Phrase: "dexamethasone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "had"

Phrase: "any effect on cell viability either"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "when"

Phrase: "given alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "or after 6h of ischemia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0022116:Ischaemia [Disease or Syndrome]
   760   C1292428:6H [Temporal Concept]
Processing 00000000.tx.117: View larger version (18K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.118: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.119: PC of neonatal rat cardiomyocytes: effects of L-NMMA and dexamethasone. 

Phrase: "PC of neonatal rat cardiomyocytes"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0225828:Cardiomyocytes [Cell]
   760   C0871117:Preconditioning [Mental Process]
   760   C1552240:Neonatal [Professional or Occupational Group]
   760   C1552264:Neonatal [Professional or Occupational Group]
   760   C2939425:Neonatal [Temporal Concept]
   726 E C1709632:Precondition [Conceptual Entity]

Phrase: ":"

Phrase: "effects of L-NMMA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "dexamethasone."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]
Processing 00000000.tx.120: Myocytes were preconditioned in the presence or absence of 1mM L-NMMA given during PC ischemia or 0.1M dexamethasone given 1h before PC. 

Phrase: "Myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596981:Myocytes [Cell]

Phrase: "were"

Phrase: "preconditioned in the presence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   737   C0871117:precondition [Mental Process]
   737   C1709632:Precondition [Conceptual Entity]

Phrase: "or"

Phrase: "absence of 1mM L-NMMA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "given during"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1442162:GIVEN [Conceptual Entity]
   833   C1550718:given [Idea or Concept]
   833   C3244317:given [Intellectual Product]
   799 E C1947971:Give [Functional Concept]

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "ischemia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022116:Ischaemia [Disease or Syndrome]
   928 E C0475224:Ischaemic [Functional Concept]

Phrase: "or"

Phrase: "0.1M dexamethasone given 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1442450:1H [Temporal Concept]

Phrase: "before"

Phrase: "PC."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]
Processing 00000000.tx.121: ***P<0.001.NS, not significant. 

Phrase: "*"

Phrase: "*"

Phrase: "*P<0.001.NS,"

Phrase: "not significant."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.122: Effect of 90-min SNAP Treatment to "Mimic" PC: Effects of ODQ, Chelerythrine, Glibenclamide, and 5-HD The effect of treatment for 90min with the NO donor SNAP to mimic PC is shown in Fig. 

Phrase: "Effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "of 90-min SNAP Treatment to """
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   788   C0039798:treatment [Functional Concept]
   788   C0087111:Treatment [Therapeutic or Preventive Procedure]
   788   C1522326:Treatment [Functional Concept]
   788   C1533734:Treatment [Therapeutic or Preventive Procedure]
   788   C1705169:Treatment [Conceptual Entity]
   788   C3538994:TREATMENT [Research Activity]

Phrase: "Mimic"

Phrase: """"

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: ":"

Phrase: "Effects of ODQ,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "Chelerythrine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0055278:chelerythrine [Organic Chemical,Pharmacologic Substance]

Phrase: "Glibenclamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "5-HD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0098450:5-hydroxydecanoate [Lipid,Pharmacologic Substance]

Phrase: "The effect of treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1518681:Treatment Effect [Finding]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "for 90min"

Phrase: "with the NO donor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0600437:nitric oxide donor [Pharmacologic Substance]
   827   C0013018:Donor [Population Group]
   827   C0040288:Donor [Population Group]
   827   C1527169:Donor NOS [Finding]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "SNAP to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   850   C0439394:s l [Quantitative Concept]
   793   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   793   C2603362:S' [Clinical Attribute]
   737 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "mimic"

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "is"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.123: 3A. 

Phrase: "3A."
Processing 00000000.tx.124: A 90-min exposure alone with SNAP (100M and 1mM) produced no deleterious effect on cell viability compared with untreated controls. 

Phrase: "A 90-min exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]

Phrase: "alone with"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0205171:Alone [Quantitative Concept]
   833   C0439044:alone [Finding]
   833   C0679994:alone [Group Attribute]

Phrase: "SNAP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   740 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(100M"

Phrase: "and"

Phrase: "1mM"

Phrase: ")"

Phrase: "produced"

Phrase: "no deleterious effect on cell viability"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "compared with untreated controls."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0332155:untreated [Finding]
   770   C1707455:Compared [Activity]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.125: However, SNAP (2mM) was associated with cytotoxicity. 

Phrase: "However,"

Phrase: "SNAP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   740 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(2mM"

Phrase: ")"

Phrase: "was"

Phrase: "associated with cytotoxicity."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   718 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.126: When cells were subjected to SI after exposure (Fig. 3B), both 100M and 1mM SNAP displayed protective effects, with 1mM SNAP producing a profound and significant protection against ischemic cell death, increasing MTT bioreduction by 64% and reducing LDH release 31.1% compared with controls (see Fig. 4). 

Phrase: "When"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subjected to SI"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0022116:Ischaemia [Disease or Syndrome]
   770   C1948023:Stimulated [Natural Phenomenon or Process]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "after exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "both 100M"

Phrase: "and"

Phrase: "1mM"

Phrase: "SNAP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   740 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "protective effects,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "with 1mM"

Phrase: "SNAP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   740 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "producing"

Phrase: "a profound"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439808:Profound [Qualitative Concept]

Phrase: "and"

Phrase: "significant protection against ischemic cell death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0524828:Cell Protection [Physiologic Function]
   753   C1545588:Protection [Finding]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "MTT bioreduction by 64%"

Phrase: "and"

Phrase: "reducing LDH release 31.1%"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   885   C0023165:lactate dehydrogenase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0022924:lactate [Organic Chemical]
   799   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030685:Release [Health Care Activity]
   799   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   799   C0391871:Release [Functional Concept]
   799   C0392756:Reducing [Qualitative Concept]
   799   C0439180:% release [Quantitative Concept]
   799   C0450355:31 [Intellectual Product]
   799   C0680255:release [Health Care Activity]
   799   C1283071:Release [Functional Concept]
   799   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.127: This protection did not differ significantly from that afforded by PC. 

Phrase: "This protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ"

Phrase: "significantly from that"

Phrase: "afforded by PC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0871117:Preconditioning [Mental Process]
Processing 00000000.tx.128: SNAP-induced protection was completely abolished by ODQ (10M) but was unaffected by the presence of chelerythrine (2M), glibenclamide (10M), or 5-HD (100M; Fig. 4). 

Phrase: "SNAP-induced protection"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   842   C0439394:s l [Quantitative Concept]
   791   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   791   C0205263:Induced [Functional Concept]
   791   C1545588:Protection [Finding]
   791   C2603362:S' [Clinical Attribute]
   735 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "abolished by ODQ (10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "but"

Phrase: "was"

Phrase: "unaffected by the presence of chelerythrine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2986417:Unaffected [Conceptual Entity]

Phrase: "(2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3171718:2M [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "5-HD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0098450:5-hydroxydecanoate [Lipid,Pharmacologic Substance]

Phrase: "(100M"

Phrase: "; Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.129: None of the inhibitors given alone had any effect on cell viability after 6h of ischemia. 

Phrase: "None of the inhibitors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "had"

Phrase: "any effect on cell viability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "after 6h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292428:6H [Temporal Concept]

Phrase: "of ischemia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022116:Ischaemia [Disease or Syndrome]
   928 E C0475224:Ischaemic [Functional Concept]
Processing 00000000.tx.130: View larger version (19K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.131: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.132: SNAP toxicity. 

Phrase: "SNAP toxicity."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   850   C0439394:s l [Quantitative Concept]
   793   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   793   C0040539:toxicity [Qualitative Concept]
   793   C0600688:Toxicity [Injury or Poisoning]
   793   C2603362:S' [Clinical Attribute]
   737 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   721 E C1407029:Toxic [Qualitative Concept]
   700 E C0032346:Poison [Hazardous or Poisonous Substance]
   700 E C1548769:Poison [Intellectual Product]
   700 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.133: A: SNAP-induced protection. 

Phrase: "A"

Phrase: ":"

Phrase: "SNAP-induced protection."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   842   C0439394:s l [Quantitative Concept]
   791   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   791   C0205263:Induced [Functional Concept]
   791   C1545588:Protection [Finding]
   791   C2603362:S' [Clinical Attribute]
   735 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.134: B: effects of 90min of pretreatment with SNAP (100M 1and 2mM) are shown untreated control cells (A) before 6h of lethal ischemia. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "effects of 90min of pretreatment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "with"

Phrase: "SNAP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   740 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(100M 1and 2mM"

Phrase: ")"

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "untreated control cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(A)"

Phrase: "before"

Phrase: "6h of lethal ischemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1292428:6H [Temporal Concept]
Processing 00000000.tx.135: ***P<0.001 View larger version (31K): [in this window] [in a new window]  Fig. 

Phrase: "*"

Phrase: "*"

Phrase: "*P<0.001 View larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0333052:Version [Functional Concept]
   799   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.136: 4.  

Phrase: "4."
Processing 00000000.tx.137: Effects ODQ, chelerythrine, glibenclamide, 5-HD on SNAP-induced PC. 

Phrase: "Effects ODQ,"

Phrase: "chelerythrine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0055278:chelerythrine [Organic Chemical,Pharmacologic Substance]

Phrase: "glibenclamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "5-HD on SNAP-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   734 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   702   C2348935:.5 L [Quantitative Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "PC."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]
Processing 00000000.tx.138: Protective effect of pretreatment with 1mM SNAP was studied in the presence or absence of ODQ (10M), chelerythrine (2M), glibenclamide (10M), and 5-HD (100M). 

Phrase: "Protective effect of pretreatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "with 1mM"

Phrase: "SNAP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   740 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "studied in the presence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   737   C0557651:Study [Manufactured Object]
   737   C2603343:Study [Research Activity]

Phrase: "or"

Phrase: "absence of ODQ (10M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: ")"

Phrase: ","

Phrase: "chelerythrine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0055278:chelerythrine [Organic Chemical,Pharmacologic Substance]

Phrase: "(2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3171718:2M [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "5-HD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0098450:5-hydroxydecanoate [Lipid,Pharmacologic Substance]

Phrase: "(100M"

Phrase: ")."
Processing 00000000.tx.139: Inhibitors were given as described in Experimental Protocols (Fig. 1). 

Phrase: "Inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "as"

Phrase: "described in Experimental Protocols"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0442711:Protocols [Intellectual Product]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   737 E C1507394:Protocol [Intellectual Product]
   737 E C1522729:Protocol [Intellectual Product]
   737 E C2348563:Protocol [Intellectual Product]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.140: ***P<0.001. 

Phrase: "*"

Phrase: "*"

Phrase: "*P<0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.141: cGMP During SNAP Treatment: Effect of ODQ SNAP caused a significant rise in cGMP level compared with the control. 

Phrase: "cGMP During"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0018338:cGMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "SNAP Treatment"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   850   C0439394:s l [Quantitative Concept]
   793   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   793   C0039798:treatment [Functional Concept]
   793   C0087111:Treatment [Therapeutic or Preventive Procedure]
   793   C1522326:Treatment [Functional Concept]
   793   C1533734:Treatment [Therapeutic or Preventive Procedure]
   793   C1705169:Treatment [Conceptual Entity]
   793   C2603362:S' [Clinical Attribute]
   793   C3538994:TREATMENT [Research Activity]
   737 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ":"

Phrase: "Effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "of ODQ SNAP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   737 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a significant rise in cGMP level"

Phrase: "compared with the control."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.142: This effect was abolished by ODQ (10M) and is shown in Fig. 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "abolished by ODQ (10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.143: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.144: View larger version (21K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.145: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.146: cGMP levels measured by RIA expressed as percentage of control untreated cells (100%) in cells exposed to 90min of treatment with 1mM SNAP. 

Phrase: "cGMP levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0018338:cGMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "measured by RIA"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0034580:RIA [Laboratory Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "expressed as percentage of control untreated cells"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   748   C0007634:Cells [Cell]
   748   C0243148:control [Qualitative Concept]
   748   C0332155:untreated [Finding]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1550141:Control [Substance]
   748   C1561533:Percentage [Idea or Concept]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(100%"

Phrase: ")"

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to 90min of treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with 1mM"

Phrase: "SNAP."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   740 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.147: Effect of 10M ODQ is also shown. 

Phrase: "Effect of 10M ODQ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "also"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.148: **P<0.01*P<0.05. 

Phrase: "*"

Phrase: "*P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "*P<0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.149: iNOS Protein Measurement During PC iNOS protein was not detected at specific time points during PC ischemia. 

Phrase: "iNOS Protein Measurement During"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0202202:Protein measurement [Laboratory Procedure]
   748   C0242485:Measurement [Functional Concept]

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "iNOS protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
   771   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected at specific time points"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   773   C2348792:Time Point [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0205369:Specific [Qualitative Concept]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1552740:specific [Intellectual Product]
   760   C3541383:Time [Temporal Concept]
   726   C1552961:Point [Quantitative Concept]
   726   C2347617:point [Quantitative Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "during"

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "ischemia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022116:Ischaemia [Disease or Syndrome]
   928 E C0475224:Ischaemic [Functional Concept]
Processing 00000000.tx.150: This is shown in Fig. 

Phrase: "This"

Phrase: "is"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.151: 6. 

Phrase: "6."
Processing 00000000.tx.152: View larger version (12K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.153: 6.  

Phrase: "6."
Processing 00000000.tx.154: Western blot probed with anti-inducible nitric oxide synthase (iNOS) polyclonal rabbit antibody. 

Phrase: "Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "probed with anti-inducible nitric oxide synthase (iNOS) polyclonal rabbit antibody."
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   806   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
           Inducible NOS
   806   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
   806   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   760   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0030015:oxide [Inorganic Chemical]
   739   C0034493:Rabbit [Mammal]
   739   C0205263:Inducible [Functional Concept]
   739   C2986642:oxide [Chemical Viewed Functionally]
   706   C0182400:Probe [Medical Device]
   706   C1704681:Probe [Gene or Genome]
   706   C2347609:Probe [Chemical Viewed Functionally]
   706   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.155: Cells were harvested for protein at 30,60,and 90min during PC ischemia. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested for protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1512335:Harvest [Health Care Activity]

Phrase: "at 30,"

Phrase: "60,"

Phrase: "and"

Phrase: "90min during"

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "ischemia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022116:Ischaemia [Disease or Syndrome]
   928 E C0475224:Ischaemic [Functional Concept]
Processing 00000000.tx.156: Mouse macrophage cell lysate was used as positive control.  

Phrase: "Mouse macrophage cell lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "was"

Phrase: "used as positive control."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   833   C1883676:Positive Control [Conceptual Entity]
   770   C0243148:control [Qualitative Concept]
   770   C0439178:% Positive [Quantitative Concept]
   770   C1273517:used [Finding]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C2825490:Positive [Qualitative Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.157: DISCUSSION TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Interest in the involvement of NO in PC was initially fuelled by knowledge that (10) the ligands adenosine (24), ACh (40), and bradykinin (11), important triggers of PC, could also generate NO by activating the endothelially derived NOS enzyme constitutive (c) NOS (22). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514811:Reference [Idea or Concept]
   760   C1706462:Reference [Conceptual Entity]

Phrase: "Interest in the involvement of NO"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   748   C0030015:oxide [Inorganic Chemical]
   748   C0543488:Interest [Mental Process]
   748   C1314939:Involvement [Functional Concept]
   748   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "in"

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "was"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "fuelled by knowledge"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0376554:Knowledge [Intellectual Product]
   756   C0556991:Fuel [Manufactured Object]

Phrase: "that"

Phrase: "(10"

Phrase: ")"

Phrase: "the ligands adenosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001443:Adenosine [Nucleic Acid, Nucleoside, or Nucleotide,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "(24"

Phrase: ")"

Phrase: ","

Phrase: "ACh (40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "bradykinin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1537501:bradykinin [Gene or Genome]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "important triggers of PC,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0032930:triggers [Clinical Attribute]
   737 E C1444748:Trigger [Qualitative Concept]

Phrase: "could"

Phrase: "also"

Phrase: "generate"

Phrase: "NO by activating"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   770   C0030015:oxide [Inorganic Chemical]
   770   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "the endothelially"

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "NOS enzyme constitutive (c) NOS"

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.158: Later, an understanding of the important role of free radicals in triggering PC (32) and the unique properties of NO both as a free radical and as a source of reactive oxygen species (29) further suggested NO as a potential target. 

Phrase: "Later,"

Phrase: "an understanding of the important role of free radicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0162340:Understanding [Mental Process]

Phrase: "in triggering"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032930:Trigger [Clinical Attribute]
   966   C1444748:Trigger [Qualitative Concept]

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "(32"

Phrase: ")"

Phrase: "and"

Phrase: "the unique properties of NO"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "both as a free radical"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0016693:Free radical [Biologically Active Substance,Chemical Viewed Structurally]
   760   C0238767:Both [Spatial Concept]
   760   C0302912:Radical [Chemical Viewed Structurally]
   760   C0332296:free [Functional Concept]
   760   C0439807:Radical [Qualitative Concept]
   760   C1706086:Both [Qualitative Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]

Phrase: "and as a source of reactive oxygen species"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0205332:Reactive [Qualitative Concept]
   744   C0449416:Source [Finding]
   744   C1515981:And [Idea or Concept]
   744   C1705919:Source [Idea or Concept]
   744   C1705920:Species [Conceptual Entity]

Phrase: "(29"

Phrase: ")"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "NO as a potential target."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0030015:oxide [Inorganic Chemical]
   753   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.159: The biological effects of NO must be set in the context of physiological tissue concentrations to put any in vitro biological response into a truly physiologically relevant context. 

Phrase: "The biological effects of NO"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0005532:Biological [Biomedical Occupation or Discipline]
   753   C0205460:biological [Qualitative Concept]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "must"

Phrase: "be"

Phrase: "set in"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1705195:Set [Conceptual Entity]

Phrase: "the context of physiological tissue concentrations to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449255:Context [Finding]
   748   C0542559:Context [Functional Concept]

Phrase: "put"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882509:Put [Activity]

Phrase: "any in vitro biological response into a truly physiologically relevant context."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   738   C0005532:Biological [Biomedical Occupation or Discipline]
   738   C0205460:biological [Qualitative Concept]
   738   C0871261:Response [Organism Attribute]
   738   C1704632:Response [Finding]
   738   C1706817:Response [Intellectual Product]
   738   C2911692:Response [Mental Process]
Processing 00000000.tx.160: The NO donor SNAP was chosen since we felt it had the most stable pharmacokinetics in our cell culture system and had a sufficiently long half-life in the context of our experimental protocols. 

Phrase: "The NO donor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0600437:nitric oxide donor [Pharmacologic Substance]
   827   C0013018:Donor [Population Group]
   827   C0040288:Donor [Population Group]
   827   C1527169:Donor NOS [Finding]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "SNAP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   740 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "since"

Phrase: "we"

Phrase: "felt"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0013987:feel [Mental Process]
   907 E C1527305:Feeling, NOS [Mental Process]

Phrase: "it"

Phrase: "had"

Phrase: "the most stable pharmacokinetics in our cell culture system"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031327:Pharmacokinetics [Physiologic Function]
   742   C0031328:pharmacokinetics [Functional Concept]

Phrase: "and"

Phrase: "had"

Phrase: "a sufficiently long half-life in the context of our experimental protocols."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0018517:Half-Life [Temporal Concept]
   736   C0376558:Life [Idea or Concept]
   736   C2825407:Half [Quantitative Concept]
   734   C0648705:half protocol [Therapeutic or Preventive Procedure]
Processing 00000000.tx.161: SNAP appears to be a low-output NO donor, and a 1mM dose gives an effective concentration of 0.460.2M after 20min (6). 

Phrase: "SNAP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   740 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a low-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "output"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709366:Output [Conceptual Entity]

Phrase: "NO donor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0600437:nitric oxide donor [Pharmacologic Substance]
   827   C0013018:Donor [Population Group]
   827   C0040288:Donor [Population Group]
   827   C1527169:Donor NOS [Finding]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "a 1mM dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0178602:Dose [Quantitative Concept]
   861   C0869039:Dose [Quantitative Concept]
   861   C1114758:Dose # [Clinical Attribute]

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "an effective concentration of 0.460.2M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "after 20min"

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.162: This compares favorably with physiological concentrations of NO found in cardiovascular tissue (21). 

Phrase: "This"

Phrase: "compares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "favorably with physiological concentrations of NO"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   748   C0030015:oxide [Inorganic Chemical]
   748   C0086045:Concentrations [Mental Process]
   748   C0205463:Physiological [Functional Concept]
   748   C2986642:oxide [Chemical Viewed Functionally]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "found in cardiovascular tissue"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0007226:Cardiovascular [Body System]
   770   C0040300:Tissue [Tissue]
   770   C0150312:Found [Quantitative Concept]
   770   C1547928:Tissue [Intellectual Product]
   737 E C0243095:Find [Finding]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.163: Therefore, we believe our SNAP responses to reflect physiologically relevant tissue levels of NO. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "believe"

Phrase: "our SNAP responses to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0871261:responses [Organism Attribute]
   756 E C1704632:Response [Finding]
   756 E C1706817:Response [Intellectual Product]
   756 E C2911692:Response [Mental Process]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "physiologically relevant tissue levels of NO."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0040300:Tissue [Tissue]
   748   C0441889:Levels [Qualitative Concept]
   748   C1547928:Tissue [Intellectual Product]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.164: This study implicates NO as an important cardioprotective agent in a cellular model of early PC. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "implicates"

Phrase: "NO as an important cardioprotective agent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   748   C0030015:oxide [Inorganic Chemical]
   748   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "in a cellular model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "of early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "PC."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]
Processing 00000000.tx.165: Significant protection against simulated ischemia is seen both by PC and with the use of the NO donor SNAP when lethal simulated ischemia is applied only after 30min of reperfusion. 

Phrase: "Significant protection against simulated ischemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1545588:Protection [Finding]

Phrase: "is"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "both by PC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0238767:Both [Spatial Concept]
   790   C0871117:Preconditioning [Mental Process]
   790   C1706086:Both [Qualitative Concept]

Phrase: "and with the use of the NO donor"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0600437:nitric oxide donor [Pharmacologic Substance]
   764   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   764   C1524063:Use of [Functional Concept]
   742   C0013018:Donor [Population Group]
   742   C0030015:oxide [Inorganic Chemical]
   742   C0040288:Donor [Population Group]
   742   C0042153:use [Functional Concept]
   742   C0457083:Use [Functional Concept]
   742   C1515981:And [Idea or Concept]
   742   C1527169:Donor NOS [Finding]
   742   C1947944:Use [Intellectual Product]
   742   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "SNAP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   740 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "when"

Phrase: "lethal simulated ischemia"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0022116:Ischaemia [Disease or Syndrome]
   827   C0284447:simulated [Biomedical or Dental Material]
   755 E C0475224:Ischaemic [Functional Concept]
   755 E C0679083:Simulation [Research Activity]

Phrase: "is"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "after"

Phrase: "30min of reperfusion."
Processing 00000000.tx.166: This observation correlates with the time course of early PC, and to our knowledge this is the only study so far documented implicating NO directly in early PC against ischemic cardiomyocyte death. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "correlates with the time course of early"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0449247:Time course [Temporal Concept]
   748   C0040223:Time [Temporal Concept]
   748   C0750729:Course [Temporal Concept]
   748   C1279919:Early [Temporal Concept]
   748   C3541383:Time [Temporal Concept]

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: ","

Phrase: "and to our knowledge"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0376554:Knowledge [Intellectual Product]
   770   C1515981:And [Idea or Concept]

Phrase: "this"

Phrase: "is"

Phrase: "the only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "so far"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037640:SO [Geographic Area]
   861   C0205108:far [Spatial Concept]

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "implicating"

Phrase: "NO directly in early"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0030015:oxide [Inorganic Chemical]
   760   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "PC against ischemic cardiomyocyte death."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   797   C0376466:Ischemic Preconditioning [Therapeutic or Preventive Procedure]
   760   C0011065:Death [Organism Function]
   760   C0225828:Cardiomyocyte [Cell]
   760   C0475224:Ischaemic [Functional Concept]
   760   C0871117:Preconditioning [Mental Process]
   760   C1306577:Death, NOS [Finding]
   726 E C1709632:Precondition [Conceptual Entity]
Processing 00000000.tx.167: Parratt (25) has previously hypothesized that endothelially derived NO from the hypoxia-induced activation of cNOS could act as a trigger for PC of the myocardium. 

Phrase: "Parratt"

Phrase: "(25"

Phrase: ")"

Phrase: "has"

Phrase: "previously"

Phrase: "hypothesized"

Phrase: "that endothelially"

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "NO from the hypoxia-induced activation of cNOS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   742   C0030015:oxide [Inorganic Chemical]
   742   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "could"

Phrase: "act as a trigger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0032930:Trigger [Clinical Attribute]
   770   C0079613:ACT [Therapeutic or Preventive Procedure]
   770   C1444748:Trigger [Qualitative Concept]

Phrase: "for"

Phrase: "PC of the myocardium."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   783   C0376442:Myocardial Preconditioning [Therapeutic or Preventive Procedure]
   770   C0027061:Myocardium [Tissue]
   770   C0871117:Preconditioning [Mental Process]
   737 E C1709632:Precondition [Conceptual Entity]
Processing 00000000.tx.168: What is striking is that NO is able to mediate protection in isolated myocytes in the absence of juxtaposed endothelial cells, suggesting an independent myocyte-derived pathway for NO generation during PC. 

Phrase: "What"

Phrase: "is"

Phrase: "striking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038452:striking [Occupational Activity]

Phrase: "is"

Phrase: "that NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "protection in isolated myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1545588:Protection [Finding]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of juxtaposed endothelial cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0225336:Endothelial Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "an independent myocyte-derived pathway for NO generation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   784   C1518332:Nitric Oxide Pathway [Molecular Function]
   742   C1704259:Pathway [Molecular Function]
   742   C1705987:Pathway [Conceptual Entity]

Phrase: "during PC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
Processing 00000000.tx.169: Our data suggest that myocyte NOS mediates PC, as the protection afforded by PC is blocked by the nonspecific NOS inhibitor L-NMMA given during PC ischemia. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that myocyte NOS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: ","

Phrase: "as"

Phrase: "the protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "afforded by PC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0871117:Preconditioning [Mental Process]

Phrase: "is"

Phrase: "blocked by the nonspecific NOS inhibitor L-NMMA"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   797   C1373060:Nitric Oxide Synthase Inhibitor [Pharmacologic Substance]
   797   C1744692:nitric-oxide synthase inhibitor [Molecular Function]
   775   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   756   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   738   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0028778:Blocked [Pathologic Function]
   738   C0030015:oxide [Inorganic Chemical]
   738   C0205370:Non-specific [Qualitative Concept]
   738   C0332206:Blocked [Functional Concept]
   738   C0750540:Nonspecific [Idea or Concept]
   738   C1999216:Inhibitor [Qualitative Concept]
   738   C2983591:BLOCKED [Research Activity]
   738   C2986642:oxide [Chemical Viewed Functionally]
   704 E C1533157:Block [Substance]
   704 E C1706084:Block [Geographic Area]
   704 E C2828370:Block [Quantitative Concept]

Phrase: "given during"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1442162:GIVEN [Conceptual Entity]
   833   C1550718:given [Idea or Concept]
   833   C3244317:given [Intellectual Product]
   799 E C1947971:Give [Functional Concept]

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "ischemia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022116:Ischaemia [Disease or Syndrome]
   928 E C0475224:Ischaemic [Functional Concept]
Processing 00000000.tx.170: Furthermore, the fact that protection is unaffected by dexamethasone pretreatment (which inhibits iNOS mRNA transcription) and that iNOS protein expression is not detected during PC ischemia suggests that protection is mediated by a Ca2+-dependent/cNOS isoform. 

Phrase: "Furthermore,"

Phrase: "the fact"

Phrase: "that protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "is"

Phrase: "unaffected by dexamethasone pretreatment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986417:Unaffected [Conceptual Entity]

Phrase: "("

Phrase: "which"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "iNOS mRNA transcription"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1158816:mRNA transcription [Genetic Function]
   799   C0040649:Transcription [Genetic Function]
   734   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
   734   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "and"

Phrase: "that iNOS protein expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1171362:protein expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
   734   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected during"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0442726:Detected [Finding]
   833   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "ischemia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022116:Ischaemia [Disease or Syndrome]
   928 E C0475224:Ischaemic [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "is"

Phrase: "mediated by a Ca2+-dependent/cNOS isoform."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   748   C0669365:CNOS [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]
Processing 00000000.tx.171: SNAP mimics PC, thus implicating NO as a trigger. 

Phrase: "SNAP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   740 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "mimics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0393040:mimics [Therapeutic or Preventive Procedure]
  1000   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: ","

Phrase: "thus"

Phrase: "implicating"

Phrase: "NO as a trigger."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0030015:oxide [Inorganic Chemical]
   760   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.172: We have further studied the downstream mechanisms of SNAP-triggered PC by studying the effects of the specific guanylyl cyclase inhibitor ODQ, the specific PKC inhibitor chelerythrine, and the inhibitors of sarcolemmal/mitochondrial ATP-sensitive K+ channels, glibenclamide and 5-HD, respectively. 

Phrase: "We"

Phrase: "have"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the downstream mechanisms of SNAP-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0030817:Penicillamine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   734 E C0699483:Cuprimine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "triggered"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032930:Trigger [Clinical Attribute]
   966   C1444748:Trigger [Qualitative Concept]

Phrase: "PC by studying"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0871117:Preconditioning [Mental Process]
   756   C0557651:Study [Manufactured Object]
   756 E C1709632:Precondition [Conceptual Entity]
   756   C2603343:Study [Research Activity]

Phrase: "the effects of the specific guanylyl cyclase inhibitor ODQ,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "the specific PKC inhibitor chelerythrine,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0055278:chelerythrine [Organic Chemical,Pharmacologic Substance]
   734   C1514555:Protein Kinase C Inhibitor [Pharmacologic Substance]
   700   C0072348:Protein C Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   700   C1418370:PROTEIN C INHIBITOR [Gene or Genome]
   700   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "the inhibitors of sarcolemmal/mitochondrial ATP-sensitive K+ channels,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0243077:inhibitors [Chemical Viewed Functionally]
   708 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "5-HD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0098450:5-hydroxydecanoate [Lipid,Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.173: The mechanism of SNAP-induced protection appears to be cGMPdependent but independent of PKC or sarcolemmal/mitochondrial ATP-sensitive K+ channel opening. 

Phrase: "The mechanism of SNAP-induced protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C1545588:Protection [Finding]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "cGMPdependent"

Phrase: "but independent of PKC"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   820 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0332291:Independent of [Functional Concept]
   783   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   783   C1168438:Protein C [Laboratory Procedure]
   783   C1418943:PROTEIN C [Gene or Genome]
   783   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0085862:Independent [Idea or Concept]
   753   C0233535:but [Mental or Behavioral Dysfunction]
   753   C1299583:Independent [Finding]

Phrase: "or"

Phrase: "sarcolemmal/mitochondrial ATP-sensitive K+ channel opening."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0175566:Opening [Spatial Concept]
   795   C1882151:Opening [Spatial Concept]
Processing 00000000.tx.174: In addition, by demonstrating that exogenous NO results in elevated cGMP levels using RIA, we have further implicated cGMP in the mechanism of NO-induced early PC. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "by"

Phrase: "demonstrating"

Phrase: "that exogenous NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "results in elevated cGMP levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0018338:cGMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205250:Elevated [Qualitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
   760   C3163633:Elevated [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RIA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034580:RIA [Laboratory Procedure]

Phrase: "we"

Phrase: "have"

Phrase: "further implicated cGMP in the mechanism of NO-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0018338:cGMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "PC."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]
Processing 00000000.tx.175: Few studies have implicated a role for NO in early PC, and these largely involve animal models of protection against pacing (36, 37) and reperfusion-induced arrhythmias (1). 

Phrase: "Few studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "implicated"

Phrase: "a role for NO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: ","

Phrase: "and"

Phrase: "these largely"

Phrase: "involve"

Phrase: "animal models of protection"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0599779:Models, Animal [Animal]
   770   C0003062:Animal [Animal]
   770   C3161035:Models [Intellectual Product]

Phrase: "against pacing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562458:Pacing [Individual Behavior]

Phrase: "(36,"

Phrase: "37"

Phrase: ")"

Phrase: "and"

Phrase: "reperfusion-induced arrhythmias"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0853339:reperfusion arrhythmias [Pathologic Function]
   827   C0003811:Arrhythmias [Pathologic Function]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.176: In studies involving the effect of PC on reperfusion-induced arrhythmias in the isolated rat heart, Bilinska et al. 

Phrase: "In studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "the effect of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "PC on reperfusion-induced arrhythmias"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   797   C0853339:reperfusion arrhythmias [Pathologic Function]
   760   C0003811:Arrhythmias [Pathologic Function]
   760   C0035124:Reperfusion [Therapeutic or Preventive Procedure]
   760   C0205263:Induced [Functional Concept]
   760   C0684253:reperfusion [Biologic Function]
   760   C0871117:Preconditioning [Mental Process]
   726 E C1709632:Precondition [Conceptual Entity]

Phrase: "in the isolated rat heart,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1882687:Rat Heart [Body Part, Organ, or Organ Component]
   827   C0018787:Heart [Body Part, Organ, or Organ Component]
   827   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "Bilinska et al."
Processing 00000000.tx.177: (1) showed that NO donors were able to mimic PC. 

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that NO donors"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0600437:Nitric Oxide Donors [Pharmacologic Substance]
  1000   C2756994:Nitric Oxide Donors [Molecular Function]
   827   C0013018:Donors [Population Group]
   827   C1527169:Donors [Finding]
   793 E C0040288:Donor [Population Group]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "mimic"

Phrase: "PC."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]
Processing 00000000.tx.178: However, Lu et al. 

Phrase: "However,"

Phrase: "Lu et al."
Processing 00000000.tx.179: (20) failed to implicate NO, as the inhibitors L-NMMA and nitro-L-arginine methyl ester did not have any effect on PC-induced protection. 

Phrase: "(20"

Phrase: ")"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "implicate"

Phrase: "NO,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "as"

Phrase: "the inhibitors L-NMMA"

Phrase: "and"

Phrase: "nitro-L-arginine methyl ester"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0052335:arginine methyl ester [Amino Acid, Peptide, or Protein]
   804   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0014898:Ester [Organic Chemical]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "any effect on"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "PC-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "induced protection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1545588:Protection [Finding]
Processing 00000000.tx.180: In this latter study, the NOS inhibitors were given before and not during PC ischemia, as in our study, which may explain the negative result. 

Phrase: "In this latter study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "the NOS inhibitors"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2757030:Nitric Oxide Synthase Inhibitors [Molecular Function]
   983 E C1373060:Nitric Oxide Synthase Inhibitor [Pharmacologic Substance]
   983 E C1744692:nitric-oxide synthase inhibitor [Molecular Function]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   779 E C1999216:Inhibitor [Qualitative Concept]
   756   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "given before"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1442162:GIVEN [Conceptual Entity]
   833   C1550718:given [Idea or Concept]
   833   C3244317:given [Intellectual Product]
   799 E C1947971:Give [Functional Concept]

Phrase: "and"

Phrase: "not during"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1518422:Not [Functional Concept]

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "ischemia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022116:Ischaemia [Disease or Syndrome]
   928 E C0475224:Ischaemic [Functional Concept]

Phrase: "as in our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "which"

Phrase: "may"

Phrase: "explain"

Phrase: "the negative result."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]
Processing 00000000.tx.181: The majority of work in the field has focused on the role of NO in late or second-window PC, and this has now been almost completely characterized. 

Phrase: "The majority of work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "in the field"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C3539073:In the Field [Spatial Concept]
           FIELD
   827   C0150312:In [Quantitative Concept]
   827   C0332285:In [Spatial Concept]
   827   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   827   C1521738:Field [Conceptual Entity]
   827   C2346620:Field [Conceptual Entity]
   827   C2349184:Field [Conceptual Entity]

Phrase: "has"

Phrase: "focused on the role of NO"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   748   C0030015:oxide [Inorganic Chemical]
   748   C0035820:Role [Social Behavior]
   748   C0205234:Focused [Spatial Concept]
   748   C1285542:focused [Functional Concept]
   748   C1705810:Role [Conceptual Entity]
   748   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "in late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205087:Late [Temporal Concept]

Phrase: "or"

Phrase: "second-window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: ","

Phrase: "and"

Phrase: "this"

Phrase: "has"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "been"

Phrase: "almost completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205197:Completely [Qualitative Concept]

Phrase: "characterized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]
Processing 00000000.tx.182: This work has been recently been reviewed by Bolli et al. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "has"

Phrase: "been"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "reviewed by Bolli et al."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0282443:reviewed [Intellectual Product]
   760   C1709940:Reviewed [Qualitative Concept]
   726 E C1552617:Review [Idea or Concept]
Processing 00000000.tx.183: (3). 

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.184: The NO hypothesis states that "late PC involves the sequential activation of different NOS isoforms in a time dependent fashion with endothelial NOS generating the NO that initiates the development of PC on day 1and iNOS then generating the NO that protects against recurrent ischemia on day 2." 

Phrase: "The NO hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1512571:Hypothesis [Idea or Concept]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "states"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1301808:State [Geographic Area]
  1000   C1442792:State [Functional Concept]
  1000   C3148680:State [Geographic Area]

Phrase: "that ""late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205087:Late [Temporal Concept]

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "involves"

Phrase: "the sequential activation of different NOS isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1879547:Activation [Activity]

Phrase: "in a time dependent fashion"

Phrase: "with endothelial NOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "generating"

Phrase: "the NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "that"

Phrase: "initiates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "the development of"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "PC on day 1and iNOS then"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   818   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
           Inducible NOS
   818   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
   818   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   764   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   742   C0030015:oxide [Inorganic Chemical]
   742   C0205263:Inducible [Functional Concept]
   742   C0332173:/day [Temporal Concept]
   742   C0439228:day [Temporal Concept]
   742   C0439505:/day [Temporal Concept]
   742   C0871117:Preconditioning [Mental Process]
   742   C1883708:Then [Temporal Concept]
   742   C2986642:oxide [Chemical Viewed Functionally]
   708 E C1709632:Precondition [Conceptual Entity]

Phrase: "generating"

Phrase: "the NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "that"

Phrase: "protects against recurrent ischemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022116:Ischaemia [Disease or Syndrome]
   770   C2945760:Recurrent [Temporal Concept]

Phrase: "on day 2."""
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]
Processing 00000000.tx.185: The mechanism is oxidant sensitive and PKC dependent. 

Phrase: "The mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "oxidant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085403:oxidant [Chemical Viewed Functionally]

Phrase: "sensitive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332324:Sensitive [Functional Concept]
  1000   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "PKC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "dependent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]
Processing 00000000.tx.186: Our results do not implicate a role for iNOS and differ importantly from these findings. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "implicate"

Phrase: "a role for iNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "differ"

Phrase: "importantly from these findings."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0243095:Finding [Finding]
   737 E C2825141:Finding [Finding]
Processing 00000000.tx.187: In the light of our data, we would propose that the mechanism of early PC by NO is cNOS dependent and is mediated via cGMP. 

Phrase: "In the light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023693:Light [Natural Phenomenon or Process]
  1000   C1306462:Light [Functional Concept]
  1000   C1881376:Light [Qualitative Concept]

Phrase: "of our data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "we"

Phrase: "would"

Phrase: "propose"

Phrase: "that"

Phrase: "the mechanism of early"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "PC by NO"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   770   C0030015:oxide [Inorganic Chemical]
   770   C0871117:Preconditioning [Mental Process]
   770   C2986642:oxide [Chemical Viewed Functionally]
   737 E C1709632:Precondition [Conceptual Entity]

Phrase: "is"

Phrase: "cNOS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0669365:CNOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "is"

Phrase: "mediated via cGMP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0018338:cGMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.188: A clear rationale exists for a protective role for cGMP against ischemia-reperfusion injury. 

Phrase: "A clear rationale"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392360:Rationale [Idea or Concept]
   861   C2699007:Rationale [Idea or Concept]

Phrase: "exists for a protective role"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
   760   C2987476:Exist [Conceptual Entity]

Phrase: "for cGMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018338:cGMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "against ischemia-reperfusion injury."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0035126:Ischemia-Reperfusion Injury [Injury or Poisoning]
           Reperfusion Injury
   964 E C0349419:Ischaemic reperfusion injury [Injury or Poisoning]
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.189: cGMP may act by 1) reducing the influx of cellular Ca2+ through L-type Ca2+ channels or 2) stimulating a cGMP-sensitive phosphodiesterase with a resultant reduction in levels of cAMP (25). 

Phrase: "cGMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018338:cGMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "may"

Phrase: "act by 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the influx of cellular Ca2+"

Phrase: "through L-type Ca2+ channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "or"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "stimulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulating [Natural Phenomenon or Process]

Phrase: "a cGMP-sensitive phosphodiesterase with a resultant reduction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031640:Phosphodiesterase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1753334:phosphodiesterase [Molecular Function]

Phrase: "in levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "of cAMP (25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.190: This together with the known effect of NO in reducing myocyte contractility (5) would serve to reduce oxygen consumption and energy demand. 

Phrase: "This together with the known effect of NO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "in reducing myocyte contractility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   755   C0026820:Contractile [Physiologic Function]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "would"

Phrase: "serve"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "oxygen consumption"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0030055:Oxygen Consumption [Clinical Attribute]
  1000   C1305742:oxygen consumption [Diagnostic Procedure]
   861   C0009830:Consumption [Activity]
   861   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1947907:Consumption [Physiologic Function]

Phrase: "and"

Phrase: "energy demand."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441516:Demand [Therapeutic or Preventive Procedure]
   861   C0699784:demand [Idea or Concept]
Processing 00000000.tx.191: A role for cGMP is further supported by a recent study that has demonstrated increased cGMP levels in the isolated perfused rat heart (18). 

Phrase: "A role for cGMP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supported by a recent"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0332185:Recent [Temporal Concept]
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "has"

Phrase: "demonstrated"

Phrase: "increased cGMP levels in the isolated perfused rat heart"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   742   C0018338:cGMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.192: However, the exact mechanism of NO-induced cytoprotection remains a subject of great debate. 

Phrase: "However,"

Phrase: "the exact mechanism of NO-induced cytoprotection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "remains"

Phrase: "a subject of great debate."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0681850:Subject [Group]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]
Processing 00000000.tx.193: NO is not only an important pathological mediator but also a powerful physiological regulator, and a better understanding of these dichotomous effects is required. 

Phrase: "NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "is"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "an important pathological mediator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "also"

Phrase: "a powerful physiological regulator,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0182953:REGULATOR [Medical Device]
   827   C1704734:Regulator [Medical Device]
   827   C1704735:Regulator [Conceptual Entity]

Phrase: "and"

Phrase: "a better understanding of these dichotomous effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162340:Understanding [Mental Process]

Phrase: "is"

Phrase: "required."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]
Processing 00000000.tx.194: Recent research suggests that redox state (17), antioxidant effects through the action of hemoxygenase (30), the regulation of apoptosis (14), and the regulation of myocardial oxygen consumption through modulation of mitochondrial function (19, 39) may underlie the basis of NO-induced cytoprotection. 

Phrase: "Recent research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that redox state"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0030012:redox state [Molecular Function]
           Redox
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "antioxidant effects through the action of hemoxygenase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C3179302:Anti-Oxidant Effects [Physiologic Function]
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "the regulation of apoptosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1148568:regulation of apoptosis [Cell Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the regulation of myocardial oxygen consumption"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "through modulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulation [Spatial Concept]

Phrase: "of mitochondrial function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "(19,"

Phrase: "39"

Phrase: ")"

Phrase: "may"

Phrase: "underlie"

Phrase: "the basis of NO-induced cytoprotection."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1527178:Basis [Functional Concept]
   748   C1874451:Basis [Pharmacologic Substance]
Processing 00000000.tx.195: In conclusion, this study shows that NO is a powerful trigger for early PC in isolated myocytes and that the PC effect is mediated probably by a cNOS isoform but is independent of iNOS. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "is"

Phrase: "a powerful trigger for early"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032930:Trigger [Clinical Attribute]
   760   C1444748:Trigger [Qualitative Concept]

Phrase: "PC in isolated myocytes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205409:Isolated [Functional Concept]
   770   C0596981:Myocytes [Cell]
   770   C0871117:Preconditioning [Mental Process]
   770   C1548221:Isolated [Idea or Concept]
   737 E C1709632:Precondition [Conceptual Entity]

Phrase: "and"

Phrase: "that"

Phrase: "the"

Phrase: "PC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "probably by a cNOS isoform"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   760   C0669365:CNOS [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0750492:Probably [Idea or Concept]

Phrase: "but"

Phrase: "is independent of iNOS."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   853   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
           Inducible NOS
   853   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
   853   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   778   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   778   C0332291:Independent of [Functional Concept]
   748   C0030015:oxide [Inorganic Chemical]
   748   C0085862:Independent [Idea or Concept]
   748   C0205263:Inducible [Functional Concept]
   748   C1299583:Independent [Finding]
   748   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.196: The mechanism of protection is dependent on cGMP, and we have demonstrated an NO-induced increase in cGMP synthesis that may lead to a number of physiological effects resulting in cytoprotection. 

Phrase: "The mechanism of protection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "dependent on cGMP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0851827:Dependent [Qualitative Concept]
   790   C1701901:Dependent [Qualitative Concept]
   790   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "an NO-induced increase in cGMP synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "that"

Phrase: "may"

Phrase: "lead to a number of physiological effects"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C1372798:Physiological Effects [Physiologic Function]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0205463:Physiological [Functional Concept]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1280500:effects [Qualitative Concept]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "resulting in cytoprotection."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332294:Resulting in [Functional Concept]
   790   C0524828:Cytoprotection [Physiologic Function]
   790   C0678226:resulting [Functional Concept]
   756 E C1274040:Result [Functional Concept]
   756 E C1546471:Result [Idea or Concept]
   756 E C2825142:Result [Finding]
Processing 00000000.tx.197: This study further adds to evolving experimental research indicating a significant cardioprotective role for NO against ischemia-reperfusion injury and should herald the reassessment and development of new pharmacological strategies for drugs with NO-modulating properties in the clinical management of ischemic heart disease.  

Phrase: "This study further adds to evolving experimental research"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1883712:Add [Functional Concept]

Phrase: "indicating"

Phrase: "a significant cardioprotective role for NO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "against ischemia-reperfusion injury"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0035126:Ischemia-Reperfusion Injury [Injury or Poisoning]
           Reperfusion Injury
   964 E C0349419:Ischaemic reperfusion injury [Injury or Poisoning]
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]

Phrase: "and"

Phrase: "should"

Phrase: "herald"

Phrase: "the reassessment"

Phrase: "and"

Phrase: "development of new pharmacological strategies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "for drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "with NO-modulating properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0871161:properties [Qualitative Concept]
   812   C1292721:properties [Functional Concept]
   779 E C1882134:Property [Conceptual Entity]
   779 E C2347695:Property [Entity]

Phrase: "in the clinical management"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1516615:Clinical Management [Health Care Activity]
   861   C0001554:Management [Occupational Activity]
   861   C0376636:management [Health Care Activity]
   861   C1273870:Management [Occupational Activity]
   861   C3273539:Management [Occupation or Discipline]

Phrase: "of ischemic heart disease."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0010054:ischaemic heart disease [Disease or Syndrome]
  1000   C0151744:Ischaemic heart disease [Disease or Syndrome]
  1000   C1313980:Ischemic heart disease [Finding]
   901   C0018799:Heart disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0018787:Heart [Body Part, Organ, or Organ Component]
   827   C0475224:Ischaemic [Functional Concept]
   827   C1281570:Heart [Body Part, Organ, or Organ Component]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.198: ACKNOWLEDGEMENTS We are grateful to Dr. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Dr."
Processing 00000000.tx.199: Albert Ferro, Department of Clinical Pharmacology, St.

Phrase: "Albert Ferro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454671:Ferro [Geographic Area]

Phrase: "Department of Clinical Pharmacology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   881   C0587459:Clinical pharmacology department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.200: Thomas' Hospital, for generous academic advice.  

Phrase: "Thomas' Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "for generous academic advice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0150600:Advice [Health Care Activity]
Processing 00000000.tx.201: FOOTNOTES The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.202: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.203: 1734 solely to indicate this fact. 

Phrase: "1734 solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.204: Address for reprint requests and other correspondence: R.D.Rakhit, Dept. of Cardiology, The Rayne Institute, St.

Phrase: "Address for reprint requests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0376649:Address [Intellectual Product]
   770   C1442065:Address [Spatial Concept]

Phrase: "and"

Phrase: "other correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "R.D.Rakhit,"

Phrase: "Dept."

Phrase: "of Cardiology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007189:Cardiology [Biomedical Occupation or Discipline]
  1000   C1555719:Cardiology [Idea or Concept]

Phrase: "The Rayne Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.205: Thomas' Hospital, Lambeth Palace Rd., London SE1 7EH, UK. 

Phrase: "Thomas' Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Lambeth Palace Rd.,"

Phrase: "London SE1 7EH,"

Phrase: "UK."
Processing 00000000.tx.206: Received 26 July 1999; 

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "26 July 1999"

Phrase: ";"
Processing 00000000.tx.207: accepted in final form 26 October 1999.  

Phrase: "accepted in final form 26 October 1999."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0205088:Final [Temporal Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1546485:Final [Idea or Concept]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.208: REFERENCES TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES 1.  

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.209: Bilinska, M, Maczewski M, and Beresewicz A. 

Phrase: "Bilinska,"

Phrase: "M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "Maczewski M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Beresewicz A."
Processing 00000000.tx.210: Donors of nitric oxide mimic effects of ischaemic preconditioning on reperfusion induced arrythmias in isolated rat heart. 

Phrase: "Donors of nitric oxide"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   881   C0600437:Nitric Oxide Donors [Pharmacologic Substance]
   881   C2756994:Nitric Oxide Donors [Molecular Function]
   770   C0013018:Donors [Population Group]
   770   C1527169:Donors [Finding]
   737 E C0040288:Donor [Population Group]

Phrase: "mimic"

Phrase: "effects of ischaemic preconditioning"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on reperfusion induced arrythmias"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0003811:Arrythmia [Pathologic Function]

Phrase: "in isolated rat heart."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1882687:Rat Heart [Body Part, Organ, or Organ Component]
   827   C0018787:Heart [Body Part, Organ, or Organ Component]
   827   C1281570:Heart [Body Part, Organ, or Organ Component]
Processing 00000000.tx.211: Mol Cell Biochem 161: 265-271, 1998. 

Phrase: "Mol Cell Biochem 161"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "265-271,"

Phrase: "1998."
Processing 00000000.tx.212: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.213: Bolli, R, Bhatti ZA, Tang X-L, Qiu Y, Zhang Q, Guo Y, and Jadoon AK. 

Phrase: "Bolli,"

Phrase: "R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bhatti ZA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037712:ZA [Geographic Area]

Phrase: "Tang X-L,"

Phrase: "Qiu Y,"

Phrase: "Zhang Q,"

Phrase: "Guo Y,"

Phrase: "and"

Phrase: "Jadoon AK."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]
Processing 00000000.tx.214: Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205087:Late [Temporal Concept]

Phrase: "preconditioning against myocardial stunning"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0206146:Myocardial Stunning [Disease or Syndrome]
   819   C0376442:Myocardial Preconditioning [Therapeutic or Preventive Procedure]
   797 E C0206145:myocardium stunning [Disease or Syndrome]
   770   C0027061:Myocardial [Tissue]
   770   C0871117:Preconditioning [Mental Process]
   770   C1522564:Myocardial [Spatial Concept]
   737 E C1709632:Precondition [Conceptual Entity]

Phrase: "in conscious rabbits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034493:Rabbit [Mammal]

Phrase: "is"

Phrase: "triggered by the generation of nitric oxide."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   778   C1444748:Triggered by [Qualitative Concept]
           Trigger
   748   C0030015:oxide [Inorganic Chemical]
   748   C0079411:Generation [Temporal Concept]
   748   C2986642:oxide [Chemical Viewed Functionally]
   748   C3146294:Generation [Activity]
   714   C0032930:Trigger [Clinical Attribute]
Processing 00000000.tx.215: Circ Res 81: 42-52, 1997[Abstract/Free FullText]. 

Phrase: "Circ Res 81"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "42-52,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.216: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.217: Bolli, R, Dawn B, Tang X-L, Qiu Y, Ping P, Xuan Y-T, Jones WK, Takano H, Guo Y, and Zhang H. 

Phrase: "Bolli,"

Phrase: "R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dawn B,"

Phrase: "Tang X-L,"

Phrase: "Qiu Y,"

Phrase: "Ping"

Phrase: "P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Xuan Y-T,"

Phrase: "Jones WK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332174:/wk [Temporal Concept]
   861   C0439230:wk [Temporal Concept]

Phrase: "Takano H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Guo Y,"

Phrase: "and"

Phrase: "Zhang H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.218: The nitric oxide hypothesis of late preconditioning (Abstract). 

Phrase: "The nitric oxide hypothesis of late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1512571:Hypothesis [Idea or Concept]

Phrase: "preconditioning"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.219: Basic Res Cardiol 93: 338, 1998. 

Phrase: "Basic Res Cardiol 93"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1527178:Basic [Functional Concept]
   812   C2347379:RES [Finding]
   741 E C0920750:basicity [Quantitative Concept]

Phrase: ":"

Phrase: "338,"

Phrase: "1998."
Processing 00000000.tx.220: 4.  

Phrase: "4."
Processing 00000000.tx.221: Bolli, R, Manchikalapudi S, Tang X-L, Takano H, Qiu Y, Guo Y, Zhang Q, and Jadoon AK. 

Phrase: "Bolli,"

Phrase: "R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Manchikalapudi S,"

Phrase: "Tang X-L,"

Phrase: "Takano H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Qiu Y,"

Phrase: "Guo Y,"

Phrase: "Zhang Q,"

Phrase: "and"

Phrase: "Jadoon AK."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]
Processing 00000000.tx.222: The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. 

Phrase: "The protective effect of late"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0543419:late effect [Finding]
   797   C1368999:Late effect [Pathologic Function]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "preconditioning against myocardial stunning"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0206146:Myocardial Stunning [Disease or Syndrome]
   819   C0376442:Myocardial Preconditioning [Therapeutic or Preventive Procedure]
   797 E C0206145:myocardium stunning [Disease or Syndrome]
   770   C0027061:Myocardial [Tissue]
   770   C0871117:Preconditioning [Mental Process]
   770   C1522564:Myocardial [Spatial Concept]
   737 E C1709632:Precondition [Conceptual Entity]

Phrase: "in conscious rabbits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034493:Rabbit [Mammal]

Phrase: "is"

Phrase: "mediated by nitric oxide synthase Evidence"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   790   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0030015:oxide [Inorganic Chemical]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0332120:Evidence [Functional Concept]
   753   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "that nitric oxide acts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0079613:ACT [Therapeutic or Preventive Procedure]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "both as a trigger"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0032930:Trigger [Clinical Attribute]
   770   C0238767:Both [Spatial Concept]
   770   C1444748:Trigger [Qualitative Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and as a mediator of the late phase of ischemic preconditioning."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   756   C0376466:Ischemic Pre-Conditioning [Therapeutic or Preventive Procedure]
   738   C0205087:Late [Temporal Concept]
   738   C0205390:Phase [Temporal Concept]
   738   C0475224:Ischaemic [Functional Concept]
   738   C0871117:Preconditioning [Mental Process]
   738   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1515981:And [Idea or Concept]
   704 E C1709632:Precondition [Conceptual Entity]
Processing 00000000.tx.223: Circ Res 81: 1094-1107, 1997[Abstract/Free FullText]. 

Phrase: "Circ Res 81"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "1094-1107,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.224: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.225: Brady, AJB, Poole-Wilson PA, Harding SE, and Warren JB. 

Phrase: "Brady,"

Phrase: "AJB,"

Phrase: "Poole-Wilson PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3541314:PA [Idea or Concept]

Phrase: "Harding SE,"

Phrase: "and"

Phrase: "Warren JB."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]
Processing 00000000.tx.226: Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. 

Phrase: "Nitric oxide production within cardiac myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "reduces"

Phrase: "their contractility in endotoxemia."
Processing 00000000.tx.227: Am J Physiol Heart Circ Physiol 263: H1963-H1966, 1992[Abstract/Free FullText]. 

Phrase: "Am"

Phrase: "J Physiol Heart Circ Physiol 263"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0018787:Heart [Body Part, Organ, or Organ Component]
   799   C0332520:Circ [Quantitative Concept]
   799   C1281570:Heart [Body Part, Organ, or Organ Component]
   799   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "H1963-H1966,"

Phrase: "1992"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.228: 6.  

Phrase: "6."
Processing 00000000.tx.229: Brorson, JR, Schumacker PT, and Zhang H. 

Phrase: "Brorson,"

Phrase: "JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Schumacker PT,"

Phrase: "and"

Phrase: "Zhang H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.230: Nitric oxide acutely inhibits neuronal energy production. 

Phrase: "Nitric oxide acutely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "neuronal energy production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033268:production [Occupational Activity]
Processing 00000000.tx.231: J Neurosci 19: 147-158, 1999[Abstract/Free FullText]. 

Phrase: "J Neurosci 19"

Phrase: ":"

Phrase: "147-158,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.232: 7.  

Phrase: "7."
Processing 00000000.tx.233: Cumming, DVE, Heads RJ, Watson A, Latchman DS, and Yellon DM. 

Phrase: "Cumming,"

Phrase: "DVE,"

Phrase: "Heads"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018670:Head [Body Location or Region]
  1000   C1281590:Head [Body Part, Organ, or Organ Component]
  1000   C1706305:HEADS [Manufactured Object]

Phrase: "RJ,"

Phrase: "Watson A,"

Phrase: "Latchman DS,"

Phrase: "and"

Phrase: "Yellon DM."
Processing 00000000.tx.234: Differential protection of rat cardiocytes by transfection of specific heat stress proteins. 

Phrase: "Differential protection of rat cardiocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1545588:Protection [Finding]

Phrase: "by transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "of specific heat stress proteins."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0018850:Stress Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0282507:heat stress [Injury or Poisoning]
   812   C0018837:Heat [Natural Phenomenon or Process]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0038435:Stress [Finding]
   741 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.235: J Mol Cell Cardiol 28: 2343-2349, 1996[ISI][Medline]. 

Phrase: "J Mol Cell Cardiol 28"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   840   C2346604:J/mol [Quantitative Concept]
   804   C0007634:Cell [Cell]
   804   C0027960:Mole [Neoplastic Process]
   804   C0324740:Mole [Mammal]
   804   C0439189:Mole [Quantitative Concept]
   804   C1269647:Cell [Cell]
   804   C1456781:mole [Neoplastic Process]
   804   C1704653:Cell [Medical Device]
   804   C1824986:mol [Gene or Genome]
   804   C1948049:Cell [Spatial Concept]
   721 E C0026367:Molar [Body Part, Organ, or Organ Component]
   704 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "2343-2349,"

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.236: 8.  

Phrase: "8."
Processing 00000000.tx.237: Du Toit, EF, McCarthy J, Miyashiro J, Opie LH, and Brunner F. 

Phrase: "Du Toit,"

Phrase: "EF,"

Phrase: "McCarthy J,"

Phrase: "Miyashiro J,"

Phrase: "Opie LH,"

Phrase: "and"

Phrase: "Brunner F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.238: Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischaemic and reperfusion function of rat isolated hearts. 

Phrase: "Effect of nitrovasodilators"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "inhibitors of nitric oxide synthase"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   900   C2757030:Nitric Oxide Synthase Inhibitors [Molecular Function]
   883 E C1373060:Nitric Oxide Synthase Inhibitor [Pharmacologic Substance]
   883 E C1744692:nitric-oxide synthase inhibitor [Molecular Function]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "on ischaemic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475224:Ischaemic [Functional Concept]

Phrase: "and"

Phrase: "reperfusion function of rat isolated hearts."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0232164:function hearts [Organ or Tissue Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
Processing 00000000.tx.239: Br J Pharmacol 123: 1159-1167, 1998[Abstract]. 

Phrase: "Br J Pharmacol 123"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "1159-1167,"

Phrase: "1998"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.240: 9.  

Phrase: "9."
Processing 00000000.tx.241: Garlid, KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, D'Alonzo AJ, Lodge NJ, Smith MA, and Grover GJ. 

Phrase: "Garlid,"

Phrase: "KD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026691:KD [Disease or Syndrome]
  1000   C1705240:KD [Gene or Genome]
  1000   C1839259:KD [Disease or Syndrome]

Phrase: "Paucek P,"

Phrase: "Yarov-Yarovoy V,"

Phrase: "Murray HN,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019905:HN [Geographic Area]
   861   C1537997:HN [Gene or Genome]
   861   C1853668:HN [Gene or Genome]

Phrase: "Darbenzio RB,"

Phrase: "D'Alonzo AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0230613:AJ [Cell Component]

Phrase: "Lodge NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Smith MA,"

Phrase: "and"

Phrase: "Grover GJ."
Processing 00000000.tx.242: Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. 

Phrase: "Cardioprotective effect of diazoxide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "its interaction with mitochondrial ATP-sensitive K+ channels."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.243: Circ Res 81: 1072-1082, 1999[Abstract/Free FullText]. 

Phrase: "Circ Res 81"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "1072-1082,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.244: 10.  

Phrase: "10."
Processing 00000000.tx.245: Gho, BCG, Eskildsen-Helmond YEG, de Zeeuw S, Lamers JMJ, and Verdouw PD. 

Phrase: "Gho,"

Phrase: "BCG,"

Phrase: "Eskildsen-Helmond YEG,"

Phrase: "de Zeeuw S,"

Phrase: "Lamers JMJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416528:JMJ [Gene or Genome]

Phrase: "and"

Phrase: "Verdouw PD."
Processing 00000000.tx.246: Does protein kinase C play a pivotal role in the mechanisms of ischemic preconditioning? 

Phrase: "Does"

Phrase: "protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a pivotal role in the mechanisms of ischemic preconditioning?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.247: Cardiovasc Drugs Ther 10: 775-786, 1996[ISI]. 

Phrase: "Cardiovasc Drugs Ther 10"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   812   C0013227:Drugs [Pharmacologic Substance]
   779 E C1254351:Drug [Pharmacologic Substance]
   741 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   741 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   712 E C0456386:Medicament [Pharmacologic Substance]

Phrase: ":"

Phrase: "775-786,"

Phrase: "1996"

Phrase: "[ISI"

Phrase: "]."
Processing 00000000.tx.248: 11.  

Phrase: "11."
Processing 00000000.tx.249: Goto, M, Liu Y, Yang X-M, Ardell JL, Cohen MV, and Downey JM. 

Phrase: "Goto,"

Phrase: "M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "Liu Y,"

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "X-M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ardell JL,"

Phrase: "Cohen MV,"

Phrase: "and"

Phrase: "Downey JM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]
Processing 00000000.tx.250: Role of bradykinin in protection of ischaemic preconditioning in rabbit hearts. 

Phrase: "Role of bradykinin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "in protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "of ischaemic preconditioning"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0376466:Ischemic Pre-Conditioning [Therapeutic or Preventive Procedure]
   861   C0475224:Ischaemic [Functional Concept]
   861   C0871117:Preconditioning [Mental Process]
   827 E C1709632:Precondition [Conceptual Entity]

Phrase: "in rabbit hearts."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0018787:Hearts [Body Part, Organ, or Organ Component]
   827 E C1281570:Heart [Body Part, Organ, or Organ Component]
Processing 00000000.tx.251: Circ Res 77: 611-621, 1995[Abstract/Free FullText]. 

Phrase: "Circ Res 77"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "611-621,"

Phrase: "1995"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.252: 12.  

Phrase: "12."
Processing 00000000.tx.253: Imagawa, J-I, Yellon DM, and Baxter GF. 

Phrase: "Imagawa,"

Phrase: "J-I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Yellon DM,"

Phrase: "and"

Phrase: "Baxter GF."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016703:GF [Geographic Area]
   861   C1551081:gf [Quantitative Concept]
Processing 00000000.tx.254: Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning. 

Phrase: "Pharmacological evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that inducible nitric oxide synthase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
  1000   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "is"

Phrase: "a mediator of delayed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "preconditioning."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]
Processing 00000000.tx.255: Br J Pharmacol 126: 701-708, 1999[Abstract/Free FullText]. 

Phrase: "Br J Pharmacol 126"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "701-708,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.256: 13.  

Phrase: "13."
Processing 00000000.tx.257: Jaburek, M, Yarov-Yarovoy V, Paucek P, and Garlid K. 

Phrase: "Jaburek,"

Phrase: "M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "Yarov-Yarovoy V,"

Phrase: "Paucek P,"

Phrase: "and"

Phrase: "Garlid K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.258: State-dependent inhibition of the mitochondrial KATP channel by glyburide and 5-hydroxydecanoate. 

Phrase: "State-dependent inhibition of the mitochondrial KATP channel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "by glyburide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glyburide [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "5-hydroxydecanoate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0098450:5-hydroxydecanoate [Lipid,Pharmacologic Substance]
Processing 00000000.tx.259: J Biol Chem 273: 13578-13582, 1998[Abstract/Free FullText]. 

Phrase: "J Biol Chem 273"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "13578-13582,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.260: 14.  

Phrase: "14."
Processing 00000000.tx.261: Kim, Y-M, Bombeck CA, and Billiar TR. 

Phrase: "Kim,"

Phrase: "Y-M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bombeck CA,"

Phrase: "and"

Phrase: "Billiar TR."
Processing 00000000.tx.262: Nitric oxide as a bifunctional regulator of apoptosis. 

Phrase: "Nitric oxide as a bifunctional regulator of apoptosis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   744   C0030015:oxide [Inorganic Chemical]
   744   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.263: Circ Res 84: 253-256, 1999[Free FullText]. 

Phrase: "Circ Res 84"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "253-256,"

Phrase: "1999"

Phrase: "[Free FullText"

Phrase: "]."
Processing 00000000.tx.264: 15.  

Phrase: "15."
Processing 00000000.tx.265: Lamas, S, Perez-Sala D, and Moncada S. 

Phrase: "Lamas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0999593:Lama [Mammal]
  1000   C1416775:LAMA [Gene or Genome]

Phrase: "S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "Perez-Sala D,"

Phrase: "and"

Phrase: "Moncada S."
Processing 00000000.tx.266: Nitric oxide: from discovery to the clinic. 

Phrase: "Nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ":"

Phrase: "from discovery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880355:Discovery [Activity]

Phrase: "to the clinic."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
  1000   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   928 E C0205210:Clinical [Qualitative Concept]
Processing 00000000.tx.267: Trends Pharmacol Sci 19: 436-438, 1998[Medline]. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Pharmacol Sci 19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "436-438,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.268: 16.  

Phrase: "16."
Processing 00000000.tx.269: Legrand, C, Bour JM, Jacob C, Capiaumont J, Martial A, Marc A, Wudtke M, Kretzmer G, Demangel C, and Duval D. 

Phrase: "Legrand,"

Phrase: "C,"

Phrase: "Bour JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Jacob C,"

Phrase: "Capiaumont J,"

Phrase: "Martial A,"

Phrase: "Marc A,"

Phrase: "Wudtke M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kretzmer G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Demangel C,"

Phrase: "and"

Phrase: "Duval D."
Processing 00000000.tx.270: Lactate dehydrogenase (LDH) activity of the number of dead cells in the medium of cultured eukaryotic cells as marker. 

Phrase: "Lactate dehydrogenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "(LDH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "activity of the number of dead cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "in the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "of cultured eukaryotic cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0007600:cultured cells [Cell]
   913   C0007635:Cultured Cells [Cell]
   913   C3282338:Cells, Cultured [Cell]
   901   C0015161:Eukaryotic Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "as marker."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.271: J Biotechnol 25: 231-243, 1992[ISI][Medline]. 

Phrase: "J Biotechnol 25"

Phrase: ":"

Phrase: "231-243,"

Phrase: "1992"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.272: 17.  

Phrase: "17."
Processing 00000000.tx.273: Lipton, SA, Choi Y-B, Pan Z-H, Lei SZ, Vincent Chen H-S, Sucher NJ, Loscalo J, Singel DJ, and Stamler JS. 

Phrase: "Lipton,"

Phrase: "SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036243:SA [Geographic Area]
  1000   C1539696:SA [Gene or Genome]
  1000   C1825840:SA [Gene or Genome]
  1000   C3539736:Sa [Spatial Concept]

Phrase: "Choi Y-B,"

Phrase: "Pan Z-H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Lei SZ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036572:sz [Sign or Symptom]
   861   C0038983:SZ [Geographic Area]
   861   C1706071:SZ [Quantitative Concept]

Phrase: "Vincent Chen H-S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0999213:Chen [Bird]

Phrase: "Sucher NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Loscalo J,"

Phrase: "Singel DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "and"

Phrase: "Stamler JS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]
Processing 00000000.tx.274: A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related compounds. 

Phrase: "A redox-based mechanism for the neuroprotective"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "neurodestructive effects of nitric oxide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "related compounds."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600686:related compounds [Chemical Viewed Structurally]
   827   C0205198:Compound [Qualitative Concept]
   827   C1706082:Compound [Chemical]
Processing 00000000.tx.275: Nature 364: 626-632, 1993[ISI][Medline]. 

Phrase: "Nature 364"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "626-632,"

Phrase: "1993"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.276: 18.  

Phrase: "18."
Processing 00000000.tx.277: Lochner, A, Genade S, Tromp E, Opie L, Moolman J, Thomas S, and Podzuweit T. 

Phrase: "Lochner,"

Phrase: "A,"

Phrase: "Genade S,"

Phrase: "Tromp E,"

Phrase: "Opie L,"

Phrase: "Moolman J,"

Phrase: "Thomas S,"

Phrase: "and"

Phrase: "Podzuweit T."
Processing 00000000.tx.278: Role of cyclic nucleotide phosphodiesterases in ischemic preconditioning. 

Phrase: "Role of cyclic nucleotide phosphodiesterases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in ischemic preconditioning."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0376466:Ischemic Pre-Conditioning [Therapeutic or Preventive Procedure]
   861   C0475224:Ischaemic [Functional Concept]
   861   C0871117:Preconditioning [Mental Process]
   827 E C1709632:Precondition [Conceptual Entity]
Processing 00000000.tx.279: Mol Cell Biochem 186: 169-175, 1998[ISI][Medline]. 

Phrase: "Mol Cell Biochem 186"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "169-175,"

Phrase: "1998"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.280: 19.  

Phrase: "19."
Processing 00000000.tx.281: Loke, KE, McConnell PI, Tuzman JM, Shesely EG, Smith CJ, Stackpole CJ, Thompson CI, Kaley G, Wolin MS, and Hintze TH. 

Phrase: "Loke,"

Phrase: "KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022558:KE [Geographic Area]

Phrase: "McConnell PI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0429863:PI [Clinical Attribute]
   861   C3537219:PI [Gene or Genome]
   861   C3539772:PI [Intellectual Product]

Phrase: "Tuzman JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Shesely EG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013715:EG [Geographic Area]
   861   C1705651:EG [Idea or Concept]

Phrase: "Smith CJ,"

Phrase: "Stackpole CJ,"

Phrase: "Thompson CI,"

Phrase: "Kaley G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Wolin MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "and"

Phrase: "Hintze TH."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039725:TH [Geographic Area]
   861   C0039738:Th [Element, Ion, or Isotope]
   861   C1420718:TH [Gene or Genome]
Processing 00000000.tx.282: Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption. 

Phrase: "Endogenous endothelial nitric oxide synthase-derived nitric oxide"

Phrase: "is"

Phrase: "a physiological regulator of myocardial oxygen consumption."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0182953:REGULATOR [Medical Device]
   748   C1704734:Regulator [Medical Device]
   748   C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.283: Circ Res 84: 840-845, 1999[Abstract/Free FullText]. 

Phrase: "Circ Res 84"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "840-845,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.284: 20.  

Phrase: "20."
Processing 00000000.tx.285: Lu, HR, Remeysen P, and De Clerck F. 

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "HR,"

Phrase: "Remeysen P,"

Phrase: "and"

Phrase: "De Clerck F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.286: Does the antiarrhythmic effect of ischemic preconditioning in rats involve the L-arginine nitric oxide pathway. 

Phrase: "Does"

Phrase: "the antiarrhythmic effect of ischemic preconditioning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "in rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "involve"

Phrase: "the L-arginine nitric oxide pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C1518332:Nitric Oxide Pathway [Molecular Function]
   804   C1704259:Pathway [Molecular Function]
   804   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.287: J Cardiovasc Pharmacol 25: 524-530, 1995[ISI][Medline]. 

Phrase: "J Cardiovasc Pharmacol 25"

Phrase: ":"

Phrase: "524-530,"

Phrase: "1995"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.288: 21.  

Phrase: "21."
Processing 00000000.tx.289: Malinski, T, Taha Z, Grunfeld S, Patton S, Kapturczak M, and Tomboulian P. 

Phrase: "Malinski,"

Phrase: "T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Taha Z,"

Phrase: "Grunfeld S,"

Phrase: "Patton S,"

Phrase: "Kapturczak M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Tomboulian P."
Processing 00000000.tx.290: Diffusion of nitric oxide in the aorta wall monitored in situ by porphyrinic microsensors. 

Phrase: "Diffusion of nitric oxide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0012222:Diffusion [Natural Phenomenon or Process]
   770   C1696141:Diffusion [Functional Concept]

Phrase: "in the aorta wall"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0677535:Wall [Manufactured Object]

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "in situ by porphyrinic microsensors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0444498:In situ [Spatial Concept]
Processing 00000000.tx.291: Biochem Biophys Res Commun 193: 1076-1082, 1993[ISI][Medline]. 

Phrase: "Biochem Biophys Res Commun 193"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "1076-1082,"

Phrase: "1993"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.292: 22.  

Phrase: "22."
Processing 00000000.tx.293: Moncada, S, Palmer RMJ, and Higgs EA. 

Phrase: "Moncada,"

Phrase: "S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "Palmer RMJ,"

Phrase: "and"

Phrase: "Higgs EA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]
Processing 00000000.tx.294: Nitric oxide: physiology, pathophysiology, and pharmacology. 

Phrase: "Nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ":"

Phrase: "physiology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "pathophysiology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031847:pathophysiology [Functional Concept]
  1000   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "and"

Phrase: "pharmacology."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031330:Pharmacology [Biomedical Occupation or Discipline]
  1000   C1524059:pharmacology [Functional Concept]
   928 E C0205464:Pharmacologic [Functional Concept]
Processing 00000000.tx.295: Pharmacol Rev 43: 109-142, 1991[ISI][Medline]. 

Phrase: "Pharmacol Rev 43"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "109-142,"

Phrase: "1991"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.296: 23.  

Phrase: "23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.297: Mosmann, T. 

Phrase: "Mosmann,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.298: Rapid colorimetric assay for cellular growth and survival: application for proliferation and cytotoxicity assays. 

Phrase: "Rapid colorimetric assay for cellular growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1516365:Cellular Assay [Research Activity]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: ":"

Phrase: "application for proliferation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0185125:Application [Health Care Activity]
   790   C1947919:Application [Intellectual Product]
   790   C2347934:Application [Intellectual Product]
   790   C3539080:APPLICATION [Quantitative Concept]

Phrase: "and"

Phrase: "cytotoxicity assays."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   966   C0201622:Cytotoxicity assay [Laboratory Procedure]
   861   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   789 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   789 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.299: J Immunol Methods 65: 55-63, 1983[ISI][Medline]. 

Phrase: "J Immunol Methods 65"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0449851:Methods [Functional Concept]
   812   C0450385:65 [Intellectual Product]
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
   779 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "55-63,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "1983"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.300: 24.  

Phrase: "24."
Processing 00000000.tx.301: Mullane, K, and Bullough D. 

Phrase: "Mullane,"

Phrase: "K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Bullough D."
Processing 00000000.tx.302: Harnessing an endogenous cardioprotective mechanism: cellular sources and sites of action of adenosine. 

Phrase: "Harnessing"

Phrase: "an endogenous cardioprotective mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: ":"

Phrase: "cellular sources"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449416:sources [Finding]
   827 E C1705919:Source [Idea or Concept]

Phrase: "and"

Phrase: "sites of action of adenosine."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   797   C0581718:action sites [Intellectual Product]
   790   C2945843:Site of [Qualitative Concept]
   760   C0205145:Sites [Spatial Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.303: J Mol Cell Cardiol 27: 1041-1054, 1995[ISI][Medline]. 

Phrase: "J Mol Cell Cardiol 27"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   840   C2346604:J/mol [Quantitative Concept]
   804   C0007634:Cell [Cell]
   804   C0027960:Mole [Neoplastic Process]
   804   C0324740:Mole [Mammal]
   804   C0439189:Mole [Quantitative Concept]
   804   C1269647:Cell [Cell]
   804   C1456781:mole [Neoplastic Process]
   804   C1704653:Cell [Medical Device]
   804   C1824986:mol [Gene or Genome]
   804   C1948049:Cell [Spatial Concept]
   721 E C0026367:Molar [Body Part, Organ, or Organ Component]
   704 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "1041-1054,"

Phrase: "1995"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.304: 25.  

Phrase: "25."
Processing 00000000.tx.305: Parratt, JR. 

Phrase: "Parratt,"

Phrase: "JR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.306: Possibilities for the pharmacological exploitation of ischaemic preconditioning. 

Phrase: "Possibilities for the pharmacological exploitation of ischaemic preconditioning."
Processing 00000000.tx.307: J Mol Cell Cardiol 27: 991-1000, 1995[ISI][Medline]. 

Phrase: "J Mol Cell Cardiol 27"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   840   C2346604:J/mol [Quantitative Concept]
   804   C0007634:Cell [Cell]
   804   C0027960:Mole [Neoplastic Process]
   804   C0324740:Mole [Mammal]
   804   C0439189:Mole [Quantitative Concept]
   804   C1269647:Cell [Cell]
   804   C1456781:mole [Neoplastic Process]
   804   C1704653:Cell [Medical Device]
   804   C1824986:mol [Gene or Genome]
   804   C1948049:Cell [Spatial Concept]
   721 E C0026367:Molar [Body Part, Organ, or Organ Component]
   704 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "991-1000,"

Phrase: "1995"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.308: 26.  

Phrase: "26."
Processing 00000000.tx.309: Ping, P, Takano H, Zhang J, Tang X-L, Qiu Y, Li RCX, Banerjee S, Dawn B, Balafonova Z, and Bolli R. 

Phrase: "Ping,"

Phrase: "P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Takano H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Zhang J,"

Phrase: "Tang X-L,"

Phrase: "Qiu Y,"

Phrase: "Li RCX,"

Phrase: "Banerjee S,"

Phrase: "Dawn B,"

Phrase: "Balafonova Z,"

Phrase: "and"

Phrase: "Bolli R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.310: Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits. 

Phrase: "Isoform-selective activation of protein kinase C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C3546691:protein kinase C activation [Molecular Function]
   804   C1819041:protein kinase activation [Cell Function]
   774   C0599177:protein activation [Genetic Function]
   748   C1879547:Activation [Activity]

Phrase: "by nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "in the heart"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018787:Heart [Body Part, Organ, or Organ Component]
  1000   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "of conscious rabbits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034493:Rabbit [Mammal]
Processing 00000000.tx.311: Circ Res 84: 587-604, 1999[Abstract/Free FullText]. 

Phrase: "Circ Res 84"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "587-604,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.312: 27.  

Phrase: "27."
Processing 00000000.tx.313: Qiu, Y, Rizvi A, Tang X-L, Manchikalapudi S, Takano H, Jadoon AK, Wu W-J, and Bolli R. 

Phrase: "Qiu,"

Phrase: "Y,"

Phrase: "Rizvi A,"

Phrase: "Tang X-L,"

Phrase: "Manchikalapudi S,"

Phrase: "Takano H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Jadoon AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: "Wu W-J,"

Phrase: "and"

Phrase: "Bolli R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.314: Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. 

Phrase: "Nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205087:Late [Temporal Concept]

Phrase: "preconditioning against myocardial infarction"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0027051:Myocardial Infarction [Disease or Syndrome]
   833   C0428953:MYOCARDIAL INFARCTION [Finding]
   833   C2926063:Myocardial infarction [Clinical Attribute]
   819   C0376442:Myocardial Preconditioning [Therapeutic or Preventive Procedure]
   770   C0021308:Infarction [Pathologic Function]
   770   C0027061:Myocardial [Tissue]
   770   C0871117:Preconditioning [Mental Process]
   770   C1522564:Myocardial [Spatial Concept]
   737 E C1709632:Precondition [Conceptual Entity]

Phrase: "in conscious rabbits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034493:Rabbit [Mammal]
Processing 00000000.tx.315: Am J Physiol Heart Circ Physiol 273: H2931-H2936, 1997[ISI][Medline]. 

Phrase: "Am"

Phrase: "J Physiol Heart Circ Physiol 273"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0018787:Heart [Body Part, Organ, or Organ Component]
   799   C0332520:Circ [Quantitative Concept]
   799   C1281570:Heart [Body Part, Organ, or Organ Component]
   799   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "H2931-H2936,"

Phrase: "1997"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.316: 28.  

Phrase: "28."
Processing 00000000.tx.317: Ripoll, C, Lederer WJ, and Nichols CG. 

Phrase: "Ripoll,"

Phrase: "C,"

Phrase: "Lederer WJ,"

Phrase: "and"

Phrase: "Nichols CG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]
Processing 00000000.tx.318: On mechanism inhibition KATP channels by glibenclamide rat ventricular myocytes. 

Phrase: "On mechanism inhibition KATP channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "by glibenclamide rat ventricular myocytes."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C2339371:Ventricular myocyte [Cell]
   812   C0018827:Ventricular [Body Part, Organ, or Organ Component]
   812   C0596981:Myocytes [Cell]
   812   C1522565:Ventricular [Spatial Concept]
   741 E C0007799:Ventricles [Body Space or Junction]
   741 E C0038351:Ventriculus [Body Part, Organ, or Organ Component]
   741 E C2355627:Ventricle [Body Part, Organ, or Organ Component]
Processing 00000000.tx.319: J Cardiovasc Electrophysiol 4: 3847, 1993. 

Phrase: "J Cardiovasc Electrophysiol 4"

Phrase: ":"

Phrase: "3847,"

Phrase: "1993."
Processing 00000000.tx.320: 29.  

Phrase: "29."
Processing 00000000.tx.321: Rubbo, H, Tarpey M, and Freeman BA. 

Phrase: "Rubbo,"

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tarpey M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Freeman BA."
Processing 00000000.tx.322: Nitric oxide reactive oxygen species in vascular injury (Abstract). 

Phrase: "Nitric oxide reactive oxygen species in vascular injury"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   800   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0205332:Reactive [Qualitative Concept]
   744   C1705920:Species [Conceptual Entity]

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.323: Biochem Soc Symp 61: 3345, 1998. 

Phrase: "Biochem Soc Symp 61"

Phrase: ":"

Phrase: "3345,"

Phrase: "1998."
Processing 00000000.tx.324: 30.  

Phrase: "30."
Processing 00000000.tx.325: Siow, RCM, Sato H, and Mann GE. 

Phrase: "Siow,"

Phrase: "RCM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1861861:RCM [Disease or Syndrome]

Phrase: "Sato H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Mann GE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:GE [Gene or Genome]
Processing 00000000.tx.326: Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: antiatherogenic actions of bilirubin and carbon monoxide. 

Phrase: "Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0037083:signalling pathway [Cell Function]
   754 E C0037080:Signal Pathway [Molecular Function]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]

Phrase: ":"

Phrase: "antiatherogenic actions of bilirubin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441472:actions [Functional Concept]
   737 E C3266814:Action [Activity]

Phrase: "and"

Phrase: "carbon monoxide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007018:Carbon Monoxide [Hazardous or Poisonous Substance,Inorganic Chemical]
   861   C0007009:Carbon [Element, Ion, or Isotope]
Processing 00000000.tx.327: Cardiovasc Res 41: 385-394, 1999[ISI][Medline]. 

Phrase: "Cardiovasc Res 41"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "385-394,"

Phrase: "1999"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.328: 31.  

Phrase: "31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.329: Sobrevia, L, Yudilevich DL, and Mann GE. 

Phrase: "Sobrevia,"

Phrase: "L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Yudilevich DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "and"

Phrase: "Mann GE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:GE [Gene or Genome]
Processing 00000000.tx.330: Activation of A2-purinoceptors by adenosine stimulates L-arginine transport (system y+) and nitric oxide synthesis in human fetal endothelial cells. 

Phrase: "Activation of A2-purinoceptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "by adenosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001443:Adenosine [Nucleic Acid, Nucleoside, or Nucleotide,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "L-arginine transport"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1159482:L-arginine transport [Cell Function]
   901   C1817788:arginine transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]
   734   C0003765:L-Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]

Phrase: "y+)"

Phrase: "and"

Phrase: "nitric oxide synthesis in human fetal endothelial cells."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C1157570:nitric oxide synthesis [Molecular Function]
   770   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   744   C0030015:oxide [Inorganic Chemical]
   744   C0220781:synthesis [Biologic Function]
   744   C1883254:Synthesis [Activity]
   744   C2986642:oxide [Chemical Viewed Functionally]
   731   C2936320:Synthetic Cells [Manufactured Object]
Processing 00000000.tx.331: J Physiol (Lond) 499: 135-140, 1997[Abstract]. 

Phrase: "J Physiol"

Phrase: "(Lond) 499"

Phrase: ":"

Phrase: "135-140,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.332: 32.  

Phrase: "32."
Processing 00000000.tx.333: Sun, JZ, Tang XL, Park SW, Qiu Y, Turrens JF, and Bolli R. 

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "JZ,"

Phrase: "Tang XL,"

Phrase: "Park SW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420193:SW [Gene or Genome]
   861   C1832169:SW [Body System]
   861   C3538902:SW [Gene or Genome]

Phrase: "Qiu Y,"

Phrase: "Turrens JF,"

Phrase: "and"

Phrase: "Bolli R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.334: Evidence for an essential role reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. 

Phrase: "Evidence for an essential role reactive oxygen species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332120:Evidence [Functional Concept]

Phrase: "in the genesis"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1414672:Genesis [Gene or Genome]
  1000   C2984892:Genesis [Gene or Genome]
   907 E C0079411:Generation [Temporal Concept]
   907 E C3146294:Generation [Activity]

Phrase: "of late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205087:Late [Temporal Concept]

Phrase: "preconditioning against myocardial stunning"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0206146:Myocardial Stunning [Disease or Syndrome]
   819   C0376442:Myocardial Preconditioning [Therapeutic or Preventive Procedure]
   797 E C0206145:myocardium stunning [Disease or Syndrome]
   770   C0027061:Myocardial [Tissue]
   770   C0871117:Preconditioning [Mental Process]
   770   C1522564:Myocardial [Spatial Concept]
   737 E C1709632:Precondition [Conceptual Entity]

Phrase: "in conscious pigs."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0039005:Pigs [Mammal]
   861   C1135183:pigs [Mammal]
   827 E C1136016:PIG [Mammal]
   827 E C1265533:Pig [Mammal]
   827 E C1270360:Pig [Mammal]
Processing 00000000.tx.335: J Clin Invest 97: 562-576, 1996[Abstract/Free FullText]. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: ":"

Phrase: "562-576,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.336: 33.  

Phrase: "33."
Processing 00000000.tx.337: Takano, H, Manchikalapudi S, Tang XL, Qiu Y, Rizvi A, Jadoon AK, Zhang Q, and Bolli R. 

Phrase: "Takano,"

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Manchikalapudi S,"

Phrase: "Tang XL,"

Phrase: "Qiu Y,"

Phrase: "Rizvi A,"

Phrase: "Jadoon AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: "Zhang Q,"

Phrase: "and"

Phrase: "Bolli R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.338: Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. 

Phrase: "Nitric oxide synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "is"

Phrase: "the mediator of late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "preconditioning against myocardial infarction"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0027051:Myocardial Infarction [Disease or Syndrome]
   833   C0428953:MYOCARDIAL INFARCTION [Finding]
   833   C2926063:Myocardial infarction [Clinical Attribute]
   819   C0376442:Myocardial Preconditioning [Therapeutic or Preventive Procedure]
   770   C0021308:Infarction [Pathologic Function]
   770   C0027061:Myocardial [Tissue]
   770   C0871117:Preconditioning [Mental Process]
   770   C1522564:Myocardial [Spatial Concept]
   737 E C1709632:Precondition [Conceptual Entity]

Phrase: "in conscious rabbits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034493:Rabbit [Mammal]
Processing 00000000.tx.339: Circulation 98: 441-449, 1998[Abstract/Free FullText]. 

Phrase: "Circulation 98"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: ":"

Phrase: "441-449,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.340: 34.  

Phrase: "34."
Processing 00000000.tx.341: Takano, H, Tang XL, Qiu Y, French BA, and Bolli R. 

Phrase: "Takano,"

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tang XL,"

Phrase: "Qiu Y,"

Phrase: "French BA,"

Phrase: "and"

Phrase: "Bolli R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.342: Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidantsensitive mechanism. 

Phrase: "Nitric oxide donors"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0600437:Nitric Oxide Donors [Pharmacologic Substance]
  1000   C2756994:Nitric Oxide Donors [Molecular Function]
   827   C0013018:Donors [Population Group]
   827   C1527169:Donors [Finding]
   793 E C0040288:Donor [Population Group]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205087:Late [Temporal Concept]

Phrase: "preconditioning against myocardial stunning"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0206146:Myocardial Stunning [Disease or Syndrome]
   819   C0376442:Myocardial Preconditioning [Therapeutic or Preventive Procedure]
   797 E C0206145:myocardium stunning [Disease or Syndrome]
   770   C0027061:Myocardial [Tissue]
   770   C0871117:Preconditioning [Mental Process]
   770   C1522564:Myocardial [Spatial Concept]
   737 E C1709632:Precondition [Conceptual Entity]

Phrase: "and"

Phrase: "infarction in conscious rabbits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0021308:Infarction [Pathologic Function]

Phrase: "via an antioxidantsensitive mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.343: Circ Res 83: 73-84, 1998[Abstract/Free FullText]. 

Phrase: "Circ Res 83"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "73-84,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.344: 35.  

Phrase: "35."
Processing 00000000.tx.345: Tsujino, M, Hirata Y, Imai T, Kanno K, Eguchi S, Ito H, and Marumo F. 

Phrase: "Tsujino,"

Phrase: "M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "Hirata Y,"

Phrase: "Imai T,"

Phrase: "Kanno K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Eguchi S,"

Phrase: "Ito H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Marumo F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.346: Induction of nitric oxide synthase gene by interleukin-1 beta in cultured rat cardiocytes. 

Phrase: "Induction of nitric oxide synthase gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0920532:gene induction [Genetic Function]
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by interleukin-1 beta"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0021753:Interleukin-1 beta [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1334112:INTERLEUKIN 1-BETA [Gene or Genome]
  1000   C1522432:interleukin-1-beta [Immunologic Factor,Pharmacologic Substance]
   901   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "in cultured rat cardiocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0225828:Cardiocyte [Cell]
   793   C2333889:Cardiocyte [Classification]
Processing 00000000.tx.347: Circulation 90: 375-383, 1994[Abstract]. 

Phrase: "Circulation 90"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0005775:Circulation [Physiologic Function]
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]
   861   C1516559:Circulation [Organism Function]

Phrase: ":"

Phrase: "375-383,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.348: 36.  

Phrase: "36."
Processing 00000000.tx.349: Vegh, A, Papp JGY, Szekeres L, and Parratt J. 

Phrase: "Vegh,"

Phrase: "A,"

Phrase: "Papp JGY,"

Phrase: "Szekeres L,"

Phrase: "and"

Phrase: "Parratt J."
Processing 00000000.tx.350: The local intracoronary administration of methylene blue prevents the pronounced antiarrhythmic affect of ischaemic preconditioning. 

Phrase: "The local intracoronary administration of methylene blue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0001554:Administration [Occupational Activity]
   748   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the pronounced antiarrhythmic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003195:Anti-arrhythmic [Pharmacologic Substance]
   861   C3537142:Anti-arrhythmic [Pharmacologic Substance]

Phrase: "affect of ischaemic preconditioning."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0376466:Ischemic Pre-Conditioning [Therapeutic or Preventive Procedure]
   770   C0001721:Affect [Mental Process]
   770   C0475224:Ischaemic [Functional Concept]
   770   C0871117:Preconditioning [Mental Process]
   737 E C1709632:Precondition [Conceptual Entity]
Processing 00000000.tx.351: Br J Pharmacol 107: 910-911, 1992[Abstract]. 

Phrase: "Br J Pharmacol 107"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "910-911,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.352: 37.  

Phrase: "37."
Processing 00000000.tx.353: Vegh, A, Szekeres L, and Parratt J. 

Phrase: "Vegh,"

Phrase: "A,"

Phrase: "Szekeres L,"

Phrase: "and"

Phrase: "Parratt J."
Processing 00000000.tx.354: Preconditioning of the ischaemic myocardium: involvement of the L-arginine nitric oxide pathway. 

Phrase: "Preconditioning of the ischaemic myocardium"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   811   C0376442:Ischemic Preconditioning, Myocardial [Therapeutic or Preventive Procedure]
           Myocardial Preconditioning
   806   C2919051:Ischemic Myocardium [Finding]
   797   C0376466:Ischemic Preconditioning [Therapeutic or Preventive Procedure]
   760   C0027061:Myocardium [Tissue]
   760   C0475224:Ischaemic [Functional Concept]
   760   C0871117:Preconditioning [Mental Process]
   726 E C1709632:Precondition [Conceptual Entity]

Phrase: ":"

Phrase: "involvement of the L-arginine nitric oxide pathway."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1314939:Involvement [Functional Concept]
Processing 00000000.tx.355: Br J Pharmacol 107: 648-652, 1992[Abstract]. 

Phrase: "Br J Pharmacol 107"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "648-652,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.356: 38.  

Phrase: "38."
Processing 00000000.tx.357: Warren, JB, Pons F, and Brady AJB Nitric oxide biology: implications for cardiovascular therapeutics. 

Phrase: "Warren,"

Phrase: "JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550751:JB [Temporal Concept]

Phrase: "Pons F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Brady AJB Nitric oxide biology"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0005532:Biology [Biomedical Occupation or Discipline]
   733 E C0205460:Biologic [Qualitative Concept]
   733 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: ":"

Phrase: "implications for cardiovascular therapeutics."
Processing 00000000.tx.358: Cardiovasc Res 28: 25-30, 1994[ISI][Medline]. 

Phrase: "Cardiovasc Res 28"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "25-30,"

Phrase: "1994"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.359: 39.  

Phrase: "39."
Processing 00000000.tx.360: Xu, ZL, Endoh H, Ishihata A, Takahashi E, and Doi K. 

Phrase: "Xu,"

Phrase: "ZL,"

Phrase: "Endoh H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ishihata A,"

Phrase: "Takahashi E,"

Phrase: "and"

Phrase: "Doi K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.361: Effect of ischaemic preconditioning on myocardial oxygen consumption during ischemia. 

Phrase: "Effect of ischaemic preconditioning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on myocardial oxygen consumption"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0428863:Myocardial oxygen consumption [Laboratory or Test Result]
   901   C0030055:Oxygen Consumption [Clinical Attribute]
   901   C1305742:oxygen consumption [Diagnostic Procedure]
   827   C0009830:Consumption [Activity]
   827   C0027061:Myocardial [Tissue]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1522564:Myocardial [Spatial Concept]
   827   C1947907:Consumption [Physiologic Function]

Phrase: "during ischemia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022116:Ischaemia [Disease or Syndrome]
   928 E C0475224:Ischaemic [Functional Concept]
Processing 00000000.tx.362: J Mol Cell Cardiol 30: 2165-2174, 1998[ISI][Medline]. 

Phrase: "J Mol Cell Cardiol 30"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   840   C2346604:J/mol [Quantitative Concept]
   804   C0007634:Cell [Cell]
   804   C0027960:Mole [Neoplastic Process]
   804   C0324740:Mole [Mammal]
   804   C0439189:Mole [Quantitative Concept]
   804   C1269647:Cell [Cell]
   804   C1456781:mole [Neoplastic Process]
   804   C1704653:Cell [Medical Device]
   804   C1824986:mol [Gene or Genome]
   804   C1948049:Cell [Spatial Concept]
   721 E C0026367:Molar [Body Part, Organ, or Organ Component]
   704 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "2165-2174,"

Phrase: "1998"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.363: 40.  

Phrase: "40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.364: Yao, Z, and Gross GJ. 

Phrase: "Yao,"

Phrase: "Z,"

Phrase: "and"

Phrase: "Gross GJ."
Processing 00000000.tx.365: Role of nitric oxide, muscarinic receptors, and the ATP-sensitive K+ channel in mediating the effects of acetylcholine to mimic preconditioning dogs. 

Phrase: "Role of nitric oxide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "muscarinic receptors,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034826:Receptors, Muscarinic [Amino Acid, Peptide, or Protein,Receptor]
   861   C0026815:muscarinic [Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "the ATP-sensitive K+ channel in"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0332324:Sensitive [Functional Concept]
   753   C0439799:Channel [Spatial Concept]
   753   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1550474:sensitive [Idea or Concept]
   753   C1706095:Channel [Conceptual Entity]
   753   C1708601:K' [Quantitative Concept]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "the effects of acetylcholine to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "mimic"

Phrase: "preconditioning"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]

Phrase: "dogs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012984:Dogs [Mammal]
  1000   C1280551:Dogs [Mammal]
Processing 00000000.tx.366: Circ Res 73: 1193-1201, 1993[Abstract]. 

Phrase: "Circ Res 73"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "1193-1201,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.367: 41.  

Phrase: "41."
Processing 00000000.tx.368: Zhao, J, Renner O, Wightman L, Sugden PH, Stewart L, Miller AD, Latchman DS, and Marber MS. 

Phrase: "Zhao,"

Phrase: "J,"

Phrase: "Renner O,"

Phrase: "Wightman L,"

Phrase: "Sugden PH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "Stewart L,"

Phrase: "Miller AD,"

Phrase: "Latchman DS,"

Phrase: "and"

Phrase: "Marber MS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]
Processing 00000000.tx.369: The expression of constitutively active isotypes of protein kinase C to investigate preconditioning. 

Phrase: "The expression of constitutively active isotypes of protein kinase C to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C1171362:expression protein [Genetic Function]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "preconditioning."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871117:Preconditioning [Mental Process]
   966 E C1709632:Precondition [Conceptual Entity]
Processing 00000000.tx.370: J Biol Chem 273: 23072-23079, 1998[Abstract/Free FullText]. 

Phrase: "J Biol Chem 273"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "23072-23079,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.371: Am J Physiol Heart Circ Physiol 278(4):H1211-H1217 0363-6135/00 $5.00 Copyright  2000 the American Physiological Society

Phrase: "Am"

Phrase: "J Physiol Heart Circ Physiol 278"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0018787:Heart [Body Part, Organ, or Organ Component]
   799   C0332520:Circ [Quantitative Concept]
   799   C1281570:Heart [Body Part, Organ, or Organ Component]
   799   C2347774:circ [Quantitative Concept]

Phrase: "(4"

Phrase: ")"

Phrase: ":"

Phrase: "H1211-H1217 0363-6135/00 $5.00 Copyright  2000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0009993:Copyright [Intellectual Product]
   791   C1552856:copyright [Idea or Concept]

Phrase: "the American Physiological Society"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0037455:society [Organization]
   827   C0205463:Physiological [Functional Concept]
   827   C0596070:American [Population Group]
   755 E C0031842:Physiology [Biomedical Occupation or Discipline]
   755 E C0031843:physiology [Physiologic Function]

